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Transfer across the placenta between mother and foetus
underlies normal foetal growth and development. Although
passive diffusion is the simplest of the several mechanisms
of transfer and despite its potential importance for foetal
growth, there have been few 'in-vivo1 measurements of
passive permeability in the human. To provide such data
passive permeability was measured 1in-vivo1 in 13
pregnancies scheduled for delivery by elective caesarean
section.
Four different sized, inert, and hydrophilic, molecular
permeants were used; mannitol, lactulose, CrEDTA, and
inulin. A bolus and constant infusion were used to create a
maternal-foetal concentration gradient. The subsequent
neonatal urinary excretion of the permeants was measured and
equalled the net transfer to the foetus as the permeants
were cleared wholly and solely by renal excretion. The
passive permeability of the placenta was calculated by
dividing the net flux by the mean transplacental
concentration gradient.
Permeability measurements for mannitol and inulin were
undertaken in 6 pregnancies, and for all four permeants in 7
pregnancies. Placental clearance (passive permeability of
the whole placenta) was (mean ± S.E. of mean) 8.1 ± 0.7
ml.rnin"1 for mannitol, 6.3 ± 0.8 for lactulose, 3.7 ± 0.5
for CrEDTA, and 0.92 ± 0.07 for mannitol. The corresponding
passive permeabilities per unit weight placenta were 13.52 ±
1.32 x 10~3 ml.min-1.g-1 for mannitol, 10.84 ± 1.55 x 10~3
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for lactulose, 6.33 ± 0.84 x 10*"3 for CrEDTA and 1.53 ± 0.11
x 10~3 for inulin.
The measured placental clearances were found to be low
compared with the blood flows on either side of the placenta
(300 - 500 ml.min"1), indicating the placenta to be a
significant barrier to passive diffusion between maternal
and foetal vascular compartments. While such a barrier will
facilitate foetal homeostasis independent of that of the
mother, the cost will be limited transfer by passive
diffusion between mother and foetus. Where the foetal
requirement exceeds this low rate of transfer, special
transfer mechanisms will be necessary to ensure adequate
foetal supply. This was concluded to be the case for
glucose, the principal foetal metabolic fuel, whereas
passive diffusion alone appeared adequate for the foetal
excretion of creatinine. The 'in-vivo' permeability data
allowed direct validation of the technique of •in-vitro'
perfusion of the isolated human placental lobule which is
widely used to obtain measurements of placental transfer
that had previously been unobtainable. This showed that 'in-
vitro ' perfusion distorted the transfer characteristics of
the placental membrane despite previous studies
demonstrating metabolic and structural integrity of the
preparation. The 'in-vivo' data also demonstrated that the
documented variation in placental permeability between the
species extends to man, making it difficult to find a single
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Plate 1. An electron micrograph of the human placental
membrane with the vasculo-syncytial region
indicated between the arrows (Courtesy of Prof TE






Placental Transfer - A General Introduction.
Historical Background.
The recognition of the importance of the placenta to the
foetus may be traced to the beginnings of recorded history.
The ancient Egyptians, for example, are believed by some
authors to have held the placenta to be the seat of the
'External Soul', as a standard interpreted as representing
the royal placenta of the Pharaohs was often carried in
ceremonial processions before the reigning Pharaoh and was
given special reverence. Although by ancient Greek times the
three membranes, the chorion, the amnion, and the allantois
were recognised, the true role of the placenta as the
conduit of transfer from mother to foetus was first
acknowledged by Aristotle (384 - 322 BC) . He described the
placenta as the source of foetal nutrition, the sanguineous
pabulum, from the mother and is also credited with being the
first to use the term chorion.
Our expanding understanding of placental function and
physiology over the intervening centuries has depended on
advances in other branches of science and has been crucially
influenced by the prevailing views of the time. Thus Galen
(circa 130 - 200 AD), the other major classical contributor
to embryology, considered the maternal and foetal vessels to
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be in continuity, and this view prevailed until the
Renaissance (circa 1453 - 1628).
Arantius (1530 - 1589) recognised that the foetal and
maternal circulations were not infact continuous and this
was a necessary prelude to Harvey's (1578 - 1657)
conclusions on the circulation and flow of blood from
arteries to veins. It was only with Malpighi's (1628 - 94)
published discription of capillaries in 1660 that the
anatomical circuit between arteries and veins was complete
and a means of separating foetal and maternal circulations
identified. Despite Malpighi's observations, the Galenic
view of an open continuity between the foetal and maternal
vessels persisted in certain quarters well into the
following century. A corollary of separate circulations was
the necessity for transfer across the placenta and in 1674
Mayow (164 0 - 1679) was able to suggest that the placenta
served as the foetal lung. Over the next couple of centuries
much work was done on comparative placental anatomy and
there was rapid progress in midwifery, but little
advancement in the study of placental function. The placenta
during this period was seen as nurturing the growing foetus
just as the roots nurture the growing plant, the only
understandable analogy available at that time.
With the establishment of separate maternal and foetal
circulations, further study of transfer between these two
very different vascular compartments depended on advances in
the physical and biological sciences. Necessary milestones
in this direction included, the isolation of oxygen in 1774
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(Priestly, 1733 - 1804) , the concept of oxidative combustion
(and hence the need for oxygen) as the source of energy for
living tissues (Lavoisier, 1743 - 1794), the demonstration
of carbon dioxide and oxygen in both arterial and venous
blood in 1837 (Magnus, 1802 - 1870) , the concept of tissue
respiration with blood merely having a carrier role and not
itself engaging in respiration or directly controlling
tissue respiration (Traube, 1826 - 1894, Pfluger, 1829-
1910), and Liebig's (1803 - 1873) apparatus allowing
division of foodstuffs into carbohydrate, fat, and protein
which led on to the identification of sugars and amino acids
in the latter half of the nineteenth century. The invention
of the spectroscope in the 1850's and its application to the
blood pigments in the 1860's by Stokes allowed Zweifel in
1876 to demonstrate the placental transfer of oxygen. In
that same year Turner could add strychnine, potassium
cyanide, and alizarian dye as substances that cross the
intact placenta 'in-vivo', and in 1888 Cohnsteinand Zuntz
showed the placental transfer of glucose in the guinea pig.
Our current understanding of the patterns and individual
mechanisms of transfer across the placental membrane
separating the maternal and foetal vascular compartments
dates from 1941. In that year Dean first proposed the
existence of an energy requiring membrane sodium pump in
muscle and in 1952 Davson and Danelli proposed their now
classic lipid bilayer as the structure for cell membranes
which has provided the basis for modern membrane physiology.
Also in 1952, Widdas suggested carrier mediated transfer in
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the placenta to explain the greater permeability of the
sheep placenta to glucose than to fructose.
Significance of placental transfer.
The foetus is completely dependent on the mother for
nutrition, respiration, and excretion. Underlying this
exchange between mother and foetus is a pattern of transfer
that provides the requirements for foetal growth at a time
when the growth rate is proportionately faster than at any
other time of life. The placenta provides this transfer.
Where placental transfer is inadequate, foetal growth is
compromised. In animals, foetal growth retardation can be
induced by experimental reduction of maternal-foetal
substrate exchange (Moll, 1985), and in man recent data from
studies of uterine blood flow (Pearse & Steel, 1988),
maternal vascular studies (Labarre, 1988) and the placental
membrane itself (Teasdale & Jean-Jacques, 1988) all suggest
inadequate placental transfer may be a major cause of
intrauterine growth retardation, a significant cause of
perinatal death and postnatal morbidity. Understanding how
the pattern of placental transfer provides the necessary
maternal-foetal exchange is thus fundamental to
understanding placental function in health and disease.
Development and structure of the human placenta.
Development.
The development of the human placenta differs in







a) Embryology of the placenta
maternal venule
decidua
^ -■ -■ -b _
':f IsmS m+mJSf mf mf m «■
yyyyvyyyy;
■;V;s -s ■%/•*■;■*; •
, ■%■s■s■s■s■s•%




















c) Histology of the placental villi in i) early and ii) late pregnancy
Fig 1. Embryology and anatomy of the human placenta
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precedent for the differences in structure and function that
make extrapolation from animal data to man so uncertain.
Faber and Thornburg (1983) list three phylogenetically
different placentas in mammals which are developed from the
chorion: chorionic (the earliest), choriovitelline (derived
from the yolk sac) and chorioallantoic (derived from the
allantois, an outgrowth from the gut caudal to the yolk
sac) . The chorionic placenta appears in all animals as the
conceptus is embedding in the endometrium but is superseded
by either of the other two types of placenta which are taken
to represent phylogenetically more advanced types of
placentation. Strictly, the chorion refers to the membrane
consisting of an outer layer of trophoblast and an inner
layer of non-vascular mesoderm.
The human placenta is usually classified as a
chorioallantoic placenta though the chorion is infact the
major foetal contributor to placental formation in man and
this is more reminiscent of the chorionic type of placenta.
The placenta in man forms from trophoblastic development,
initially present over the whole of the chorionic sac, but
which soon becomes confined to an area beneath the growing
embryo, with regression elsewhere (Fig la) . Though a yolk
sac develops it does not form a choriovitelline placenta as
in the rat or even persist as a functioning yolk sac
placenta throughout gestation as in the guinea pig; and
though an allantois also develops and even grows into the
body stalk, it does not make contact with the chorion to
form a true chorioallantoic placenta as in the sheep but its
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vessels provide the necessary connection between the
embryonic vascular channels and the developing placenta
(hence its classification as a chorioallantoic placenta).
The trophoblastic development forms bulges into the maternal
endometrium, the so-called primary villi. As the
trophoblastic development occurs the outer trophoblastic
layer looses its intercellular boundaries to become a
syncytium, the syncytiotrophoblast, while the deeper lying
cells retain distinct cell boundaries, the cytotrophoblast.
These primary villi acquire a connective tissue core from
mesenchymal ingrowth and as they grow they destroy the
adjacent maternal endometrium including blood vessels. The
invading villi therefore come to lie surrounded by maternal
blood with the syncytiotrophoblast in direct contact with
the blood, an arrangement that is one of the characteristics
of the functioning human placenta for the rest of gestation
(fig lb) .
The syncytiotrophoblast, while being the only epithelial
syncytium in man, is not the only syncytium, striated
skeletal muscle for example being a multinucleate syncytium.
The syncitial nature of skeletal muscle is presumably a
specific adaption because both smooth and cardiac muscle are
mono-nucleate and it is tempting to speculate that the
syncytiotrophoblast has a similar and specific adaptive
function. By its very nature, the syncytiotrophoblast has no
paracellular pathways of transfer which are very important
in other epithelia, for example the intestine.
During pregnancy the placenta continues to grow and
develop and between 28 weeks and term (4 0 weeks) the
placenta doubles in weight from 3 00 g to 600 g while the
foetus increases in weight by a factor of three from 1 kg to
3.5 kg. New villi are still being formed at term (Fox, 1979)
though the branching process has substantially reduced the
diameter of the villi to around 40 fj m. The villous surface
area also increases substantially during pregnancy. Aherne
and Dunhill (Aherne & Dunnill, 1969) estimated the surface
area of the syncytiotrophoblast exposed to the maternal
circulation to be 3.4 m2 at 28 weeks, increasing to 11 m2 at
term (excluding the microvilli). The syncytiotrophoblast is
at its most attenuated in the terminal villi and it is here
that the foetal and maternal blood are in closest apposition
and it is here that most exchange is believed to take place.
Structure of the human placental membrane.
In early pregnancy the placental membrane between
maternal and foetal vascular compartments consists of the
three tissue layers: foetal capillary endothelium, mesoderm,
and trophoblast. The cytotrophoblast layer of the
trophoblast regresses after the second month and the
syncytiotrophoblast becomes attenuated, from 10 ^m to about
1.7 j^m in late gestation (Boyd & Hamilton, 1967), so that
most villi come to lie clothed in a reduced
syncytiotrophoblast layer with only the occasional
cytotrophoblastic cell persisting (Fig lc). Other changes
with gestation also serve to bring the two circulations into
closer apposition: the foetal villous vessels increase in
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diameter, they also move from a central to a more peripheral
position, the microvilli covering the syncytial surface
increase in number from 600 million.cm"2 at the fourteenth
week to 1200 million.cm"2 at term (Ludwig, 1974), and in the
late pregnancy there develop areas of focal attenuation of
the syncytiotrophoblast, called vasculo-syncytial membranes,
where there is an absence of nuclei and the syncytium
appears particularly closely applied to the capillary
basement membrane (Fig lc) . The exact functions of the
microvilli and vasculo-syncitial membranes are unclear.
While these microvilli certainly increase the surface area,
Fox (1979) quotes papers showing their dissimilarity with
the absorptive intestinal microvilli indicating possibly a
greater role in foetal excretion than accretion, and also
showing their absence over the surface of the vasculo-
syncitial membranes suggesting they play no role in gas
exchange. Stacey (1990), however, suggests that these areas
provide specialized sites for the transport of
macromolecular substances such as immunoglobulins, as this
obviates the need for crossing an interstitial space.
Species variability.
The chorio-allantoic placenta shows more variability
among species than virtually any other organ, not only in
its development as already touched upon, but also in its
structure. Thus the rabbit, rat, and guinea pig placenta
have their foetal blood vessels interconnected to form a
complex capillary network, among which maternal blood spaces
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intertwine, the labyrinthine arrangement, in contrast to the
villous arrangement of the human and sheep placenta. The
number of tissue layers between the maternal and foetal
blood varies between the species, varying from five in the
sheep to three in the human. Even the cytotrophoblast may be
present as a single, double, or triple layer depending on
the species. The structural variation of some animal
placentas' is listed in table 1 indicating the structural
diversity despite a common function.
Grosser (1927) attempted to classify placentas on the
basis of the number of tissue layers between maternal and
foetal blood with the prediction of an inverse correlation
between placental permeability and the number of its
component tissue layers and thickness. Grosser's scheme has
however been much criticised: there is no correlation
between the thickness of the placental membrane and the
number of its component layers (Faber & Thornburg, 1983) and
electron microscopy has shown one of Grosser's placental
types to have been misclassified (Lawn et al, 1969).
Nevertheless, the scheme has withstood the test of time and
remains the most useful placental classification system.
Overview of the mechanisms of placental transfer.
While the placental membrane functions as a single
morphophysiological unit, it is infact composed of three
different tissue layers, trophoblast, mesoderm, and
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a) The placental membrane













lumen of foetal capillary
b) Transport mechanisms across the placental membrane (after Morris and Boyd,1988)
i) diffusion of lipophilic substances, ii) diffusion of hydrophilic substances,
iii) facilitated diffusion, iv) active transport, v) transcytosis, vi) transcapillary mechanisms.
Fig 2. The placental barrier and its transport mechanisms
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not necessarily have the same permeability characteristics
and transport mechanisms, and indeed are likely to be quite
dissimilar.
a) Trophoblast. The syncytiotrophoblast is a syncytium
with few if any mechanisms for paracellular transport while
the cytotrophoblast is a discontinuous layer.
b) Mesoderm. This is absent in the vasculo-syncytial
membrane where it is represented merely by a basement
membrane which is a continuous feltwork around the foetal
capillaries composed of glycoproteins, collagen and other
fibrillar substances that is likely to act as a size and
charge barrier.
c) Capillary endothelium. The foetal capillary
endothelium has intercellular junctions but unlike visceral
capillary endothelium which has transcellular circular
openings called fenestrae, electron microscopy has shown the
foetal capillary endothelium to be of the continuous type,
lacking these transcellular openings. The intercellular
junctions in the foetal capillary will allow paracellular as
well as transcellular mechanisms of transport compared to
the transcellular routes that are the only means of transfer
across the syncitiotrophoblast.
Transfer across those of the above tissue layers which
are entirely cellular will involve transfer across cell
membranes. Membrane structure is therefore a major
influence on the mechanisms of placental transfer. Cell
membranes in the placenta, like cell membranes elsewhere,
are constructed of a bilayer of amphipathic lipid made up of
phospholipids, glycolipids and cholesterol. A diagramatic
representation of a lipid bilayer is shown in Figure 3b).
All cell membranes contain protein, for example membrane
receptors and transport proteins, and many of the proteins
are infact glycosylated. At 37°C the membrane lipids are in
a fluid state and this allows both lipid and protein to
diffuse laterally in the bilayer, the proteins to undergo
conformational change, and endocytosis and exocytosis to
occur. While proteins are dispersed in the membrane in five
possible ways, membrane transport carriers are likely to
span the width of the membrane, Figure 3c).
Specific mechanisms of placental transfer (Ficr 2b) .
(a) Transcellular
The term transcellular is applied when the transfer
occurs across cells and in the case of the placenta is
applicable to the foetal capillary endothelium and
syncytiotrophoblast. Transcellular transfer involves four
main mechanisms:
(i) Lipophilic. Lipid soluble substances for example the
respiratory gases, unconjugated bilirubin, and alcohol cross
the placenta readily. This is explained by the ease with
which lipophilic substances dissolve in the lipid bilayer
structure of the cell membrane. This is evidenced by the
correlation between lipid solubility as measured by
partition coefficient (olive oil/water) and the substance's
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a) Relationship between the permeability of several non-electrolvtes towards
cells of the giant algae Nitella mucronata and their relative oil solubility.









ii) Arrangement of membrane lipids in the bilayer of a plasma membrane
(after Evans and Graham, 1989)
Fig 3. Permeability and structure of the cell membrane
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In the human placenta permeability for carbon monoxide is
295 x 103 ml.min"1, compared with a maternal uterine blood
flow of 500 ml.min"1, foetal umbilical blood flow of 350
ml.min"1, and permeability for Na+ of 20 ml.min"1 (data in
Faber & Thornburg, 1983) demonstrating the high permeability
to lipids.
(ii) Hydrophilic transfer. Hydrophilic substances will
only slowly, if at all, dissolve in the lipid bilayer so
that there must be a different mechanism of transfer from
lipophilic transfer. Inert hydrophilic molecules, with a
distribution limited to the extracellular space, do cross
the placenta and their permeability is approximately
proportional to their diffusion coefficients in water. This
has been taken as evidence of transfer across the placental
membrane by agueous channels or pores. In the case of the
syncyt iotrophoblast these pores would have to be
transcellular. There have been many efforts to visualize
these channels or pores by electron microscopy but all to
date have been unsuccessful (Stulc, 1989) . It has indeed
been questioned whether such water-filled pores need to
exist as distinct entities as some of their postulated
dimensions are only about twice those of a water molecule.
The permeability data more precisely refers to 'notional'
pores which may be just areas of free volume created by
thermal fluctuation of the lipid hydrocarbon chain or spaces
between the highly oriented hydrocarbon tails of the quasi-
crystalline array of membrane lipids into which water
partitions (Reeves & Dowben, 1970, Bittman & Blau, 1972), or
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actual water-filled channels, formed either as transient
pores in the lipid membrane, or 'fixed' and consisting of
channels lined by a three-dimensional meshwork of glyocalyx
fibres creating a molecular size-selective filter or two
dimensional cylindrical apertures in the cell membrane
(Michel, 1980) . While the permeability data for the sheep
are compatible with a 'notional' pore of radius 0.4 - 0.5 nm
(Boyd, Haworth, Stacey, et al, 1976) the data for the rabbit
(Stulc, Friedrich, & Jiricka, 1969), guinea pig (Hedley &
Bradbury, 1980) and rat (Robinson, Atkinson, Jones, et al,
1988; Stulc, 1989) indicate a non-uniform radius for the
pores, some of which would have to be between ten to thirty
times wider than those measured in the sheep.
(iii) Carrier mediated transfer. This refers to transfer
mediated by a specific carrier mechanism usually a protein.
It is stereospecif ic and saturable and is of two types,
facilitated and active.
Facilitated transfer operates down an electrochemical
potential gradient and moves substances at a faster rate
than would have occurred by simple diffusion. It does not
require the expenditure of cellular energy.
Active transfer is similar to facilitated transfer but
transfers against an electrochemical potential and is an
energy requiring process. There is much 'in-vivo' (largely
in animals) and 'in-vitro' evidence that glucose crosses the
placenta by facilitated transfer and •in-vitro' evidence
only that lactate does likewise. Foetal accumulation of
amino acids, some vitamins, and ions such as calcium and
phosphate, against a concentration gradient is 'in-vivo'
evidence of active transport that can be supported by ' in-
vitro* studies.
(iv) Transcytosis and endocytosis.
Transcytosis refers to transfer across the cell by
membrane-bound vesicles and endocytosis (receptor mediated
or fluid phase) if the vesicles are destined for consumption
within the cell itself. Transcytosis has been most clearly
established in the case of the yolk sac placenta of lower
animals where it accounts for all the transplacental
transfer of IgG during the latter stages of pregnancy in the
guinea pig. In the human it is believed to underlie the
placental transfer of IgG that is quantitatively most
significant in the third trimester. It is likely to be
receptor mediated as there are Fc receptors on the
trophoblast (Johnson & Brown, 1981) and endothelium from
villous stem vessels (Matre & Johnson, 1977).
(b) Paracellular
This pattern of transfer in the placenta is only present
in the capillary endothelium. The ultrastructure of human
placental capillary endothelium has been less extensively
studied than in many other animals. The endothelium is of
the continuous variety lacking the significant number of
fenestrations which are found in other capillary beds, for
example pancreas, jejunum, and kidney and contains
intercellular junctions that are similar in structure to
those described in the guinea pig placenta which are
penetrable by molecules up to 6 nm in diameter (Firth,
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Bauman, & Sibley, 1983); the permeability of these latter
junctions in the human has not been similarily
systematically studied. Physiologically important molecules
above 6 nm in diameter which would be excluded by these
junctions include albumin (7 nm approx), and most other
plasma proteins.
(c) Other relevant factors affecting placental transfer.
(i). Solvent drag. This refers to the enhanced transfer of
solute that occurs with water movements. It has been little
studied in the human placenta but as the net foetal
accumulation of water at term is of the order of 25 ml.day-1
(Hytten, 1979), the effect of solvent drag might be expected
to be minimal. It certainly appears to be unimportant in the
case of sodium transfer across the sheep placenta (Weedon,
Stacey, Ward, & Boyd, 1978)
(ii) . Electrical effects. In the human the maternal-
foetal potential difference is small in the pre-term infant
at -2.7 mV, and insignificantly diffferent from zero at term
(Morriss & Boyd,1988). While the ability of the placental
membrane to discriminate against the charge on molecules has
not been investigated in the human, such charge
discrimination has been raised as a distinct posibility in
the guinea pig placenta which shares with the human a
haemomonochorial structure (Hedley & Bradbury, 1980).
'In-vivo' animal studies of placental permeability.
•In-vivo1 animal studies suggest that placentas may be
divided into two groups on the basis of their passive
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permeability characteristics; those like the sheep which
present a tight barrier barely permeable to CrEDTA and
impermeable to inulin and with permeabilty decreasing
rapidly with increasing molecular size; and the others like
the guinea pig, rat, and rabbit which are much more
permeable to the larger molecules and whose permeability
decreases much less with increasing molecular size (Faber &
Thornburg, 1983) . The values for placental permeability in
these species are listed in Table 2.
(i) Placental permeability in the sheep.
The main investigations in this animal were performed by the
group at University College Hospital, London and reported by
Boyd et al (1976). These authors studied a chronically
catherized sheep preparation with a bolus or infusion of
permeant into either the foetal or maternal circulation. The
permeants used were 14[C] urea, 14[C] erythritol, and 3 [H]
mannitol, and their concentration in the opposing
circulation was measured. By measuring the uterine blood
flow, the uterine arterio-venous tracer concentration
difference, and the transplacental concentration gradient, a
placental clearance for the tracers in ml.min"1 was
calculated.
(ii) Placental permeability in the rabbit.
This work was reported by Stulc, Friedrich, and Jiricka
(19 69) . Like the work on the sheep it used a catheterized
animal preparation but acutely, not chronically,
catheterized and just as importantly, the foetal side was
artificially perfused at a predetermined rate with exogenous
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donor blood. A placental clearance was derived as in the
sheep.
(iii) Placental permeability in the guinea pig.
There have been two reported studies of 'in-vivo' placental
permeability in this species, Thornburg & Faber (1977) and
Hedley & Bradbury (1980). The former authors used a
chronically catheterized preparation but a second
anaesthetic was required for the study as catheters for
vascular access were inserted on the maternal side at this
time (the first anaesthetic was used to ligate the vitelline
vessels and so exclude the yoke sac placenta). The maternal
side was perfused and a placental clearance calculated for
14[C] urea, 3[H] mannitol, and 14[C] inulin by measuring the
total foetal uptake at set times. Hedley & Bradbury (1980)
used an acutely prepared preparation with intravenous
injection of tracer to label the blood perfusing the
maternal side and similarily calculate a placental clearance
for 14[C] erythritol, 51[Cr] EDTA, and FITC Dextran 3000
(Table 1) . These authors, however repeated the experiment
but perfusing the foetal side with a physiological salt
solution with the placenta still 'in-situ' within the
uterus, and calculated a clearance by measuring the uptake
of permeant into the fluid perfusing the umbilical
circulation. This resulted in the clearance of 14 [C]
erythritol doubling, that for 51[Cr] EDTA trebling, and that
for FITC-Dextran 3000 quadrupling compared with the intact
foetal circulation.
(iv) Placental permeability in the rat.
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Two studies have been undertaken on the rat with the
placenta perfused 1in-vivo1. Stulc and Stulcova (1986) used
an acutely catheterised preparation of the rat placenta
with an artificial perfusate to measure the transfer of
radiolabelled mannitol, sucrose, raffinose, inulin from the
maternal to the foetal side. Robinson et al (1988) used
maternal injection of radiolabelled mannitol, sucrose,
CrEDTA, inulin, and albumin and subsequent foetal
accumulation to measure placental permeability in the intact
placenta and a preparation similar to that of Stulc and
Stulcova to provide parallel information about the placenta
perfused 'in-vivo'. These authors found that, unlike Hedley
and Bradbury (1980), there was no significant increase in
permeability with perfusion of the placenta.
Although the above 'in-vivo1 animal studies of placental
permeability provide comparative data for the present study,
they illustrate the difficulties in choosing the most
appropriate animal model for the human placenta and also the
change in permeability that may arise from artificial
perfusion. It does appear however, that haemochorial
placentas (rabbit, guinea pig, and rat) as a group have
different permeability characteristics to those of
epithel iochor ial placentas (sheep) indicating that
structural complexity may have some functional significance
(Grosser, (1927). Nevertheless, in the search for a suitable
animal model for the human placenta histological similarity
cannot be assumed to imply functional similarity.
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Chapter 2.
Passive permeability studies of the human placenta.
Introduction.
Free diffusion is the simplest form of transfer
across biological membranes and a logical starting point for
any study of placental transfer. The rate of free
diffusion is a function of passive permeability, and
measuring the rate of diffusion across the human placenta
will allow the passive permeability of the placental
membrane to be calculated. The passive permeability of the
placental membrane is a fundamental characteristic that
reveals much about its structure and function.
Most previous studies of passive permeability in the human
placenta have used 1in-vitro* preparations for technical and
ethical reasons. Few 1in-vivo' studies have been performed
and these have used only single permeants so that different
data have to be combined to construct a permeability
profile.
'In-vitro' studies.
These are of two main types: intact preparations, using
artificial perfusion of a part usually a lobule of the
placenta, and isolated preparations, using isolated
placental tissue either placental slices or placental
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villous tissue, specially prepared microvillous membrane
vesicles, or trophoblast cell cultures.
(i). 'In-vitro1 perfusion of the human placental lobule.
This technique involves cannulating the placenta
immediately after delivery to establish circulations on the
foetal and maternal sides of the placenta. The foetal side
is perfused through a cannulated artery and vein on the
periphery of the placenta, and the maternal side perfused by
two cannulae inserted into the intervillous space demarcated
by perfusion of the foetal side. The maternal perfusate
returns through multiple venous openings in the decidual
plate and is continuously collected (Illsley, Aarnoudse,
Penfold et al, 1984). Using this technique, the passive
permeability of the placenta to a range of hydrophilic
permeants has been measured, Table 2, p 33. Although
technically difficult and requiring considerable expertise,
the technique allows ready access to placental tissue and a
wide range of studies to be undertaken.
There are however, several limitations of the technique.
As many of the placentas studied by this technique are from
vaginal deliveries there is the possibility of altered
function from the stress of labour. Even though all possible
measures are taken to ensure placental viability, there is
still an interval between the delivery of the placenta and
the establishment of perfusion, during which time the
placenta may suffer metabolic damage. The perfusate has to
be a physiological buffer and whether the perfusion flow and
pressures exactly duplicate those found 'in-vivo' remains
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uncertain. Exchange and perfusion may not be uniform
throughout the placenta and this has two consequences for
the technique of 'in-vitro' perfusion. Firstly, the lobule
chosen for 1in-vitro' perfusion may not be representative of
the placenta as a whole and secondly, 'in-vitro• perfusion
may alter the distribution and balance of perfusion within
the lobule leading to altered placental exchange,
(ii). Isolated placental tissue preparations.
These techniques provide information about cellular
uptake which is not the same as transfer across the
placental membrane. However, such studies are the only way
at present that information about the individual tissue
layers of the placental membrane can be obtained. Studies
with directly dissected villous tissue have shown it to have
a large extracellular water space that is only slowly
penetrated by inulin (Smith & Depper, 1974), indicating that
the trophoblast provides a major barrier to free diffusion.
Studies with isolated microvillous membrane vesicles have
demonstrated and localized a similar barrier to free
diffusion not only to the syncytiotrophoblast plasma
membrane, but to its maternally facing side (Smith, 1981;
Bissonnette 1981).
1In-vivo1 studies.
There have been various studies attempting to measure the
'in-vivo1 permeability of the human placenta to a variety of
3855 s* - ♦ I
permeants. The first systematic study was by Flexner and co¬
workers (Flexner, Cowie, Hellman, et al, 1948) who measured
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the placental transfer of 24[Na] at term and the end of the
first trimester. The authors used a maternal injection of
radiolabelled sodium, and measured its disappearance from
the maternal circulation and its appearance in the foetal
circulation at birth. From a volume of distribution factor
for the foetal plasma concentration, a unidirectional flux
for sodium was calculated, expressed as milligrams of sodium
transferred per gram of placenta per hour. Sodium, however
is not inert and transferred solely by passive diffusion as
there exist in the placenta specific sodium transport
mechanisms, for example Na - amino acid co-transport (Boyd,
1981). Studies of the placental transfer of 125[I] insulin
(Kalhan, Schwartz, & Adam, 1974) are subject to similar
criticisms as insulin is a biologically active molecule with
a short half-life.
Other studies attempting to measure placental transfer
have been undertaken with either tracer analogues or inert,
hydrophilic, molecules. Holmberg and colleagues, (Holmberg,
Kaplan, Karvonen, et al, 1956) studied the placental
transfer of D-xylose, a supposedly inert aldopentose also
used in gut permeability studies, and fructose. Willis et al
(Willis, 0'Grady, Faber et al, 1986) used cyanocobalamin,
and Thornburg et al, (Thornburg, Burry, Adams et al, 1988)
used inulin. The data of Holmberg et al (1956) only give
maternal-foetal concentration gradients with no measure of
net flux; a true permeability cannot be calculated but the
data do allow the transfer of fructose and xylose to be
compared with that of glucose. This comparison shows the
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transfer of fructose to be one tenth that of glucose and the
transfer of D-xylose to be intermediate between that of
glucose and fructose which agrees with other studies of the
stereospecificity of placental glucose transport (Johnson &
Smith, 1980). Xylose has also been shown to be a poor marker
of placental permeability in the sheep (Stacey, Weedon,
Haworth et al, 1978) where its transfer was consistent with
a shared transfer mechanism with D-glucose. The permeability
studies with cyanocobalamin and inulin were single permeant
studies which introduces further errors when trying to
combine the data due to the marked individual variability in
permeability that is such a feature of animal placentas.
The available data on the 'in-vivo' permeability
characteristics of the human placenta are thus very limited.
Summary of background.
Exchange between the maternal and foetal vascular
compartments across the placenta underlies normal foetal
growth and development as it provides the necessary-
nutrients and removes the accumulating metabolic waste
products. There are few 1in-vivo' data on placental transfer
in the human because of the technical and ethical
difficulties in undertaking these essentially clinical
studies. Attention has therefore focused on animal and 1 in-
vitro' studies as a means of obtaining data on placental
function which may be applicable to man. Animal studies are
however of uncertain relevance to man because the known
structural and functional differences between the different
animal placentas may extend to the human and this has not
been explored by comparative studies of animal and human
placental function. 'In-vitro' studies provide data on the
human placenta, but their applicability to the 'in-vivo'
situation is again unproven. There are doubts about both the
viability of the placenta when perfused 'in-vitro1 and the
validity of the results obtained by this technique.
Placental tissue preparations give information about
transport mechanisms but no information about quantitative
foetal transfer; there is also no proof that the transfer
mechanisms demonstrated 1in-vitro1 have necessarily the same
function 'in-vivo'.
The few ' in-vivo' studies that have been performed have
analyzed the data slightly differently (see discussion) and
only one permeant has been used at a time. The data are not
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strictly comparable and the large inter-placental variation
will further limit the sensitivity of the combined data.
Measurements of placental transfer are thus required for
understanding normal placental function and as a
prerequisite for demonstrating abnormal transfer.
Hydrophilic transfer (passive diffusion) is the pattern of
transfer examined in this study. It is: the simplest form of
transfer across the placental membrane; a fundamental
characteristic of the placental membrane; the starting point
for any study of membrane transfer characteristics; and one
of the mechanisms of placental transfer available for all
smaller, hydrophilic molecules such as the inert permeants
used in this study, and molecules of biochemical and
nutritional importance such as D-glucose, creatinine, urea,
amino acids, and thyroxine.
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Aims of the research.
1. To measure the placental permeability of the human
placenta 'in-vivo1 to a range of inert, hydrophilic,
molecular permeants that will allow the construction of a
permeability profile. This will provide a measurement of
placental exchange available to the foetus through passive
diffusion.
2. To analyze the data in terms of one of the theories of
membrane transfer, namely pore theory, to ascertain whether
the data from the human placenta are consistent with this
theory.
3. To provide 'in-vivo1 permeability data that can be
directly compared with 1in-vitro' placental perfusion data
(DK Copas & MJ Landon) obtained in the same group of
placentas.
4. To provide 'in-vivo' permeability data from the human
that can be compared with similar data from other animal
species that will help in the identification of suitable
animal models for human placental function.
5. To provide measurements of placental permeability that
can be compared with similar measurements in pregnancies
where there is disordered foetal growth, and foetal transfer
might be expected to be abnormal, for example idiopathic






All the studies were performed in pregnancies at term
which were scheduled for delivery by elective caesarian
section for reasons other than foetal or placental
abnormality, for example breach presentation, unstable lie,
or previous caesarian section. Such women were identified
from the labour ward work book a few days before the
scheduled day of delivery. On the day of admission, that is
the day before delivery, both the prospective mother and
father were approached, the nature of the project explained,
and consent sought from both. Only when this was given was
the study undertaken. Pregnancies were not studied when
there was any risk of foetal abnormality or when the nursing
staff were concerned about the mother's psychological state.
Approximately half of the couples approached agreed to
participate.
The infusate was prepared on the morning of delivery. For
the studies using only mannitol and inulin the infusate was
prepared on the ward just before clinical use; for the
studies with all four permeants, mannitol, lactulose,
CrEDTA, and inulin, the infusate was prepared for clinical
use by the pharmacy department that morning. About one hour
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before the scheduled time of caesarian section a large bore,
14 G cannula was inserted into a maternal arm vein. A large ^
bore cannula was standard anaesthetic practice to permit
the administration fluids and drugs and in case large
amounts of fluid had to be given rapidly. The pre-infusion
blood sample was withdrawn through the cannula while all
subsequent blood samples were obtained by a small butterfly
needle inserted into a contralateral arm vein; deadspace was
*r|
withdrawn and patency maintained with heparinized saline. A
maternal urine sample was obtained at the time of urethral
catheterization which was done routinely for caesarian
section and was performed before the infusion was commenced.
A bolus of the infusate was followed by a continuous
infusion until the time of delivery. The two infusates were
given at a different rate to keep the amount of administered
mannitol and inulin approximately the same despite the
different composition of the two infusates. The two infusion
regimes are listed in Table 3.
Table 3. The two different infusion regimes used.
Infusate Volume of bolus Rate of continuous
composition infusion
Mannitol/ 100 ml 60 ml.hr"1
inulin
Mannitol/inulin/ 165 ml 99 ml.hr"1
CrEDTA/lactulose
Permeant composition of each regime is
detailed in materials section, page 86.
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The infusion rate was controlled with an IVAC infusion pump,
model 531, and the bolus given as free flow under gravity,
approximately 10 minutes for mannitol and inulin, and 15
minutes for the solution with the four probes. Maternal
blood samples were taken at approximately 2 0 minute
intervals during the infusion. The exact length of the
infusion was determined by the schedule on the delivery
suite.
At delivery a sample of venous cord blood and if possible
amniotic fluid was obtained. Neonatal urine was collected
into a small plastic urine bag glued onto the perineum with
medical grade adhesive, Dow Corning 355 Medical Grade
Adhesive. The urine bag was continuously aspirated with a
vacuum pressure of 4 0cm water (plate 2) . This allowed the
infant a normal amount of freedom and the mother to provide
as much care for the infant as she wanted in the first
couple of days, bearing in mind that the mother has just had
a caesarian section with a midline abdominal incision. The
urine collection was maintained for between 50 to 60 hours
and the urine was collected as separate timed collections.
The urine was either analysed straight away, or more
usually, frozen for analysis later. The blood was allowed to
separate and the serum and amniotic fluid frozen until
analysed.
The protocol and procedures were approved by the
hospital/clinical research centre ethical committee.
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Permeants.
Four permeants were used (Fig 4).
(i) Inulin.
Inulin is a linear fructose polymer with one terminal
glucose residue which is obtained from the tubers of Dahlia
variabilis, Helianthus tuberous, and other genera of the
family Compositae. The average molecular weight is 5000-
5500 daltons, indicating aproximately 30 sugar residues per
inulin molecule. Molecular radius has been calculated at
approximately 1.4nm (from sources in Normand, Olver,
Reynolds and Strang 1971). It is an inert, non-metabolizable
and hydrophilic molecule that has long been used as a marker
for the extracellular space or the measurement of glomerular
filtration rate (GFR). Continuous infusion of inulin has
been used safely to measure maternal GFR in pregnancy
(Davison & Hytten 1974).
Brandes, Abramovici & Peretz (1971) were the first to
show that inulin given intravenously to the mother, passed
across the placenta into foetal venous blood and urine, and
entered amniotic fluid in measureable amounts. Other studies
by the same group (Brandes, Abramovici & Reich 1970) using
paper chromatography showed that the inulin transferred
across the placenta remained as a polymer but as it was
compared with the monosaccharides fructose, glucose, and
raffinose, and remained at the origin of the chromatogram, a
change in the molecular size distribution;-was not excluded.
(ii) CrEDTA.

































Fig 4. Placental permeants used in the current study
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acid (EDTA) with Cr(lll) . EDTA chelates a wide spectrum of
metals with a high formation constant that ensures the metal
ion remains firmly bound in the complex. CrEDTA is:
physiologically inert, not bound by plasma proteins, does
not penetrate red blood cells, is not taken up or metabol¬
ized by any organ other than the kidneys which filter it in
a manner virtually identical to that of inulin, and in
adults 98% of an administered dose is excreted by the
kidneys within 24 hours (Amersham data sheet). The use of
51[Cr] EDTA to measure GFR was first reported in 1966 and is
now a standard technique in both adults and children. 51[Cr]
EDTA has more recently (Maxton, Bjarnason, Reynolds, et al,
1986) been used as a marker in intestinal permeability
studies. CrEDTA therefore is thought to be a safe permeant
for studying placental permeability with the added advantage i
that it is not a saccharide like the other three permeants
providing a form of internal control for the study. 51[Cr]
EDTA being radioactive could not be used during pregnancy,
but non-radiolabelled CrEDTA could be safely used instead
with measurement through assay of the elemental chromium.
The Cr(111)EDTA complex is a complicated and
controversial compound that has chromium complexed with EDTA
in an equimolar ratio. The molecular weight of the complex
is 3 87 as the disodium salt. The complex of Cr(lll) with
EDTA is generally accepted to be pentadentate, with the Cr
bound to the EDTA complex at 5 sites. The shape of the
molecule is a distorted octahedron with a surrounding
hydration shell that contains up to 6 water molecules.
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The standard dose of 51CrEDTA for GFR measurement is 4 0-
8 0 jaCi corresponding to 40 - 80 jag of elemental chromium
(specific activity of supplied 51CrEDTA approximately 1
jiCi.jigCr"1) . The normal dietary intake of elemental chromium
is 60 - 100 ^ig.day-1 and the total body content 6 mg
(Venugopal & Luckey, 1978). The normal urinary concentration
of elemental chromium is approximately 1 jag.l"1, and by
analogy with the placental transfer of mannitol which was
already known, a bolus and infusion of 100 ;ag elemental
chromium corresponding to 0.8 mg of CrEDTA were likely to
give satisfactory foetal blood and urinary levels. This dose
did not contain greater than the daily intake of elemental
chromium, and the dose of EDTA was well below the upper
limit of 50 mg.kg"1.day-1 recommended for its therapeutic
use as a chelating agent.
(iii) Lactulose.
Lactulose (4-0-J3-D Galactopyranosyl D-fructofuranose)
molecular weight 342, is a disaccharide consisting of one
molecule of galactose joined to one molecule of fructose. It
is inert, not metabolised within the body, and there is no
evidence of endogenous production. Its volume of
distribution is limited to the extracellular fluid space,
and its excretion is wholly and solely by the kidney. Less
than one percent of ingested lactulose is absorbed from the
neonatal intestine, at a period when the intestine is
especially permeable to intact sugars and proteins. After an
intravenous injection 95% of the injected dose is
recoverable in the urine (Menzies, 1983; Weaver, Laker, and
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Nelson, 1984). Lactulose is infact present in some 'ready to
feed' liquid infant milks. It is formed as result of the
terminal sterilisation used in the preparation of these
feeds which converts up to 6% of the lactose into lactulose
(Beach, and Menzies, 1984).
Lactulose is widely used as a safe osmotic laxative with
a usual dose for an adult being 20 g twice daily. In hepatic
encepathalopathy, where lactulose has a special place in
removing protein from the gut, doses of 3 0 g three times
daily are recommmended. Lactulose has been widely used as a
marker to investigate intestinal permeability in adults and
more recently for similar studies in the neonatal period
(Weaver, Laker, and Nelson, 1984)
(iv) Mannitol.
Mannitol is a monosaccharide with molecular weight of
182. It is inert, and not metabolised within the body.
Endogenous production has been suggested in adults but
Weaver et al (1984) could find no evidence of this in the
neonates they studied. Like lactulose, mannitol is a normal
constituent of several proprietary infant milk feeds but is
absent from breast milk. Its volume of distribution is the
same as lactulose, namely the extracellular fluid (though it
does penetrate red blood cells slowly 'in-vitro'), and its
excretion is similarily by the kidney, with 95% of an
intravenous dose being recoverable in the urine (Menzies,
1984) . Less than 5% of orally administered mannitol is
absorbed in the neonatal period.
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Basso, Fernandez, Althabe, et al, (1977) were the first
to show that mannitol given to the mother just before
delivery passed across the placenta and could be detected in
the amniotic fluid where the concentrations exceeded those
in maternal blood. Levels in cord blood were not measured.
Mannitol is widely used as one of the few effective
therapies for raised intracranial pressure largely outside
the neonatal period, but at all ages, including the
neonatal, is used as an osmotic diuretic in the therapy of
renal failure. Adult doses of mannitol vary from 50 - 200 g
over 24 hours; the neonatal dose is guoted as 1 - 2 g.kg-1
body weight, well in excess of our measured net transfer to
the foetus of 200 - 400 mg.
All four permeants are inert, hydrophilic, markers that
are wholly and solely cleared by the kidney: they are





Inulin was assayed by the method of Heyrovsky (Heyrovsky
1956). This uses an alcoholic solution of purified indol-
3yl-acetic acid to identify the fructose end product of
inulin hydrolysis. In the presence of fructose and
concentrated hydrochloric acid this reagent gives a
quantitative purple-blue colour. This reaction is claimed to
53.
be of relatively high specificity and sensitivity with only
fructose and fructose containing saccharides giving the
reaction in comparable concentrations; interference by
glucose is stated to be of the order of 0.5 - 1 %. As
proteins in the urine do not interfere with the reaction
deproteinization of this fluid is not necessary.
Reagents:
All reagents used for the inulin assay were
obtained from BDH Ltd. Dagenham, Essex.
A 0.5g.l00 ml-1 solution of 4 indol-3yl-acetic
acid was prepared by adding 12 5 mg of the pure
crystalline material to 25 ml 96% ethanol alcohol
(Analar) and vortex mixed until fully dissolved. This
solution was kept at 4°C and remade as necessary.
Inulin standards were prepared from chemical
grade inulin powder. A stock solution of 1 mg.ml-1 was
made by dissolving 50 mg of inulin in 20 - 25 ml
distilled water, heating till dissolved, and then
making up to 50 ml with distilled water. This stock
solution was then diluted 1, 2, 4, 6, and 8ml to 100
ml distilled water to give the working standards 10,
20, 40, 60, and 8 0 ^lg.ml-1. Where other standards were
required, for example 120 and 160 jig.ml-1, these were
prepared in a similar manner from the same stock
solution.
Trichloroacetic acid was prepared as a 20 g.100
ml"1 solution in distilled water.
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Sample preparation:
(1) Serum & Amniotic fluid. 250 p.1 of serum or
amniotic fluid was added to 1.25 ml of distilled water
and 1 ml of 2 0% trichloracteic acid solution and
vortex mixed. The specimen was then spun for 5 minutes
at 2500 rpm and the crystal clear supernatant removed
for subsquent assay. Dilution of the original sample
was thus 1:10.
(2) Urine & Infusate. The urine and infusate
samples were diluted accordingly: infant urine 1 in
10 (0.5ml to 4.5ml dist. H20)
maternal urine 1
in 250 (4 00^.1 to 100 ml dist H20)
infusate 1 in 1000
(250jil to 250ml dist H20)
The dilutions of the urine specimens were performed as
soon as possible after the urine was collected to
minimize the precipitation of inulin (Robertson,
Hytten, & Cheyne 1970) and to bring the inulin
concentration within the range of the prepared
standards.
Assay technique:
To 0.5 ml of the diluted urine, serum or
amniotic filtrate, blank (distilled water) and
standards, 100 ul of indol-3yl-acetic acid solution
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and 4 ml of concentrated hydrochloric acid (SG 1.18
Analar) was added and vortex mixed. This mixture was
incubated in a water bath in screw capped glass tubes
at 37°C for 75 minutes, cooled in cold tap water for a
further 3 0 minutes and then read at 53 0 nm against a
water blank. Each assay was performed in duplicate and
the mean of the two results taken.
The sample value was read off against the standards
run with each assay (Fig 5) and the inulin
concentration in the original sample determined by
multiplying this value by the dilution made. The
accuracy of the assay was checked in two ways.
(1) The intra-assay variability was assessed by
multiple assays of the same sample; 12 determinations
gave a range of 53 - 59 ^lg.ml-1, mean 56 and standard
error of the mean 0.6
(2) As inulin is extremely stable the same
standards were able to be used for up to 4 months.
When a new set of standards was made up it was checked
against the old one. The difference between the two
was always less than 5%.
Column Chromatography.
Column chromatography using Sephadex gel filtration
columns was used firstly, to confirm the identity of the
inulin being measured and secondly, to separate the inulin
from interfering lower molecular weight substances when
quantifying the neonatal urinary inulin excretion. In both
Concentrationofstandard(|ig.ml"1)
Fig5.StandardcurveofHey ovskyreactionwi hinul n andlactulosestandards
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cases the same basic technique was used though the grade of
Sephadex and the length of column varied. The eluent was 0.1
mmolar phosphate bufferd saline, PBS, (exact composition
NaCl 9.3 mM, KC1 0.2 mM, NaHP04 0.05 mM, and KH2P04 0.1 mM )
and 0.02 g.dl-1 azide was added to prevent bacterial growth.
Potassium dichromate and blue dextran were used to
characterise the columns. The sample volume was less than
0.5 ml for the 15 cm column and 1 ml for the 4 0 cm column.
The elution rate was 2 ml.hr-1 and the fraction volume 600
jal. 3[H] inulin (Amersham International) was used as
internal standard (approximately 0.4 JiCi) and was measured
by scintillation counting on a LKB 1215 Rackbeta. The
samples were prepared by adding 4 ml of scintillant to 100
jj.1 of the eluent. Limits for counting were set at 100
seconds and 10 K.
Identity of Excreted Inulin.
Gel filtration chromatography on Sephadex G-50 confirmed
that the infused inulin was not significantly changed by
passage through the placenta into foetal fluids (Fig 6) .
Sephadex G-50 was chosen as inulin lay within its range of
separation of polysaccharides (Pharmacia, 1985) . The
molecular size distribution of infused inulin was compared
with that appearing in the foetal and maternal urine. A 15 x
1 cm column was used. Inulin is a polydisperse molecule and
the prolonged tail on the chromatogram is due to lower
molecular weight forms. The 3[H] inulin is also shown to be
of slightly lower molecular weight than the chemical inulin;
I0.4-
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this is also the case for 14[C] inulin (Coulthard & Ruddock,
1983) . Amniotic fluid was analysed separately on a 40 x 1 cm
column. The concentration of inulin was much lower in the
amniotic fluid and in all cases in which sufficient amniotic
fluid was available for analysis there was
chromatographically identifiable inulin present, but the
peak of inulin was sometimes barely above background. In Fig
6 the profile of chemically pure inulin has been
superimposed to help identify the inulin in amniotic fluid.
When there was insufficient inulin in the sample to be
applied to the column to give a good sized peak it was
necessary to concentrate the sample by freeze drying. This
was the case for all the samples of amniotic fluid and the
most dilute of the urine collections. The sample was first
shell-frozen, and then dried at -10°C with a vacuum of 0.5
Torr ("67 Nm-2). The recoveries on 2 samples after freeze
drying were 90 and 110%.
Measurement of Inulin in Body Fluids.
In the body fluids under study there were substances that
cross-reacted in the assay for inulin that were not inulin.
These were allowed for in different ways depending on
whether the body fluid was either serum, or urine and
amniotic fluid. In the second group of patient-studies where
lactulose was infused, the lactulose cross-reacted with the
inulin because of its fructose component. This was allowed
for in sera or urine in a similar manner to that of the
cross-reacting material.
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(1) Serum. In the patient-studies in group 1 where only
mannitol and inulin were infused, serum measurements of
inulin were performed as above. In the patient-studies in
group 2, where the Heyrovsky reaction measured both the
inulin and lactulose present, inulin could not be measured
directly. The concentration of lactulose was first measured
by gas chromatography and converted to an optical density
from a calibration curve constructed from a range of
lactulose standards assayed as for inulin and run with each
assay. The calculated optical density for the measured
lactulose concentration was then subtracted from the optical
density measurement of the sample to obtain the optical
density due to inulin itself and this was read off the
inulin standard curve as previously to give the true inulin
value.
(2) Urine and amniotic fluid. The blank value for neonatal
urine in the inulin assay varied between neonates and the
time after delivery (figs 7 & 8), rendering invalid the
simple subtraction of a single value for background that
would apply to all patient-studies. Gel filtration
chromatography using Sephadex G-50 was therefore used to
separate the inulin from the background activity and
quantify it.
Column chromatography was carried out with the standard
technique outlined previously. A representative sample,
usually 10 ml, of the total neonatal urinary excretion was
prepared by taking proportionate amounts of each individual












Fig 7. Neonatal urinary excretion of inulin activity
















sample was applied to a Sephadex column to achieve a large
enough peak of inulin activity such that the highest value
was still within the range of the standard curve. Where the
urine volume was large it was sometimes necessary to
concentrate the representative urine sample by freeze drying
a measured volume and resuspending it in a smaller volume.
Out of each 600 ^1 aliquot collected, 500 ;al was assayed by
the method of Heyrovsky for inulin and 100 p.1 scintillation
counted for 3[H] inulin. In the first group of patients
studied, a 40 x 1 cm column of Sephadex G-50 (fine) produced
satisfactory separation from the cross-reacting material
(fig 9) .
In the second group of patient-studies where lactulose was
infused a Sephadex G-25 (superfine) (40 x 1 column) was
necessary for adequate separation of the larger sized inulin
from the smaller sized cross-reacting lactulose which was
present in a much higher concentration (Fig 10) . On the
Sephadex G-25, inulin eluted at the void volume of the
column while lactulose appeared in the middle of the elution
volume coincident with the naturally occuring cross-reacting
substance.
The amount of inulin in the proportionate urine sample
was calculated from its peak area on the chromatogram. The
optical density measurements of the inulin curve, identified
by 3[H] inulin, were summated and divided by the number of
fractions over which it was collected to give a mean optical
density which was converted into a mean inulin concentration
(^lg.ml-1) by reading off the standard curve. This was
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Fig 9. Column chromatography of the representative pooled









O S*f@1 °=FO£ ]
0.4.
0.6-






















Fig10.Columnchro atographyfrepresentativep oledsa pl st t ln n aluri collections(group2patient-studies)
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related to the amount of inulin applied to the column in mg.
by the equation,
Inulin applied = Mean inulin x Number of x 0.6
to column (pg) concentration fractions
(jig/ml)
0.6., the given fraction volume
The fraction volume of 600 jal was checked by collecting 6
fractions into weighed vials and then reweighing: mean 594
jjg ± 1 (± S.E. of mean) .
The accuracy of measuring inulin by peak area
measurements on a Sephadex column as above was determined by
running the column with several standard amounts of chemical
inulin and applying the above procedure to quantify the
inulin eluting from the column. This was done for both the
Sephadex G-50 and G-25 columns (Fig 11); slope 1.03, r =
0.997, n = 9. The G-25 column could not be used with more
than 33 0 p.g of inulin as due to its elution at the void
volume, the peak was much narrower and with the larger
amounts of inulin, the peak optical density exceeded that of
the standards used.
Time Course of Inulin Excretion.
Inulin excretion was essentially complete within the time
course of the urine collection. This was indicated by two
sets of observations. Firstly, in the 6 patient-studies with
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Inulin recovered from column (jig)
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Fig14.Backgroundcross-reactingmateri lint rn laneo atalc troluri e
71.
just inulin and mannitol, its excretion was 90% completed
within 48 hours of birth (Fig 12). The concentration
profiles all showed the excretion falling to an apparent
baseline, suggesting that the excretion had reached
background by the time urine collection ceased. Secondly,
column chromatography on serial urine samples (Fig 13)
could demonstrate no significant inulin in the terminal
urine samples corresponding to the baseline, the inulin
activity being almost entirely due to the background lower
molecular weight material.
Nature of Background Material.
In all the samples of maternal and foetal urine and
amniotic fluid examined for inulin by the Heyrovsky reaction
there was present a lower molecular weight substance that
eluted in a fixed position to inulin. In the 15 cm column
the interfering substance eluted 7-8 fractions after 3[H]
Inulin, and 10 - 11 fractions after 3[H] Inulin in the 40 cm
column. This is the same position in which lactulose elutes,
indicating a molecular weight of approximately 300 compared
with that of 5200 for inulin itself. The column
chromatography does not prove that the interfering substance
is a single compound; it may be a mixture of different
compounds.
This interfering substance or background material was
present in both maternal and neonatal control urine(fig 14).
The neonatal control urines examined gave blank values of
between 0.2 - 0.5 mg.ml"1 over the first 24 - 36 hours (Fig
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7) , equivalent to between 2 0 - 50 mg for a urine output of
100 ml. This is the same order of magnitude as found in the
neonatal urine collection of infused patient-studies where
mannitol and inulin alone were used, suggesting that inulin
degradation made little or no contribution to the
interfering substance.
The nature of the background material was investigated by
sugar analysis (Dr E Hounsell) and mass spectrometry (Dr A
Lawson) at the Clinical Research Centre. Sample fractions of
neonatal urine containing the interfering substance were
identified and obtained by the standard technique of column
chromatography. Sugar analysis showed that the prepared
samples contained a 1:1 mixture of galactose and glucose and
mass spectrometry though not conclusive, gave a peak with
the ion of lactose but with the comment that there were
probably other carbohydrates present. There are certainly a
whole range of mono-and disaccharides excreted in the urine,
some of which are dietary in origin (Pitkanen, 1972, &
Bickel, 1961).
Stability of the Inulin.
The long term stability of the manufactured inulin was
assessed by column chromatography. An aliquot of time
expired 12 g.dl-1 inulin solution that had been manufactured
3 years previously was eluted on Sephadex G-50 using the
standard technique above. This was compared with 2 different
inulin infusates that had been chromatographed 1 year and 3
months respectively, after manufacture (Fig 15) .
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Patient-study L: Inulin 1 year after manufacture Time expired: Inulin 3 years after manufacture
Patient-study F: Inulin 1 month after manufacture
Fraction Number
Fig 15. Stability of the infused inulin
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This shows that after 3 years approximately 5% of the inulin
in solution may undergo decomposition to smaller sized
fragments. Inulin chromatographed 1 year and 3 months after
manufacture showed no detectable degradation. The
manufactured inulin had a shelf-life of one year arbitarily
put on it by the pharmacy department and a new batch of
inulin was manufactured after 18 months. The oldest inulin
used for patient-studies was therefore 18 months post
manufacture, and degradation of the infused inulin therefore
minimal.
Interaction of inulin with lactulose.
Lactulose gives a positive reaction in the Heyrovsky
assay due to its fructose component. Just as with inulin
this reaction is linear over the same concentration range
(fig 5) and this permits its subtraction when assaying serum
and amniotic fluid samples containing both inulin and
lactulose to determine the inulin concentration. To confirm
that the optical density measurements were additive and
there was no interaction between inulin and lactulose, and
the subtraction therefore valid, a multiple linear
regression analysis was performed on a matrix of a
combination of inulin and lactulose concentrations in plasma
and water. The analysis was performed by the Department of
Medical Statistics, St George's Hospital (Dr M Bland), using
the GLIM programme on an IBM computer. The regression
analysis was performed with the equation,
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OD = bD + b^I + b2L + b3I.L + E
OD : Optical Density
bQ to b3 : constants
I : inulin, L : lactulose
The analysis showed an interaction achieving significance at
the 5% level only, and that ignoring this would cause an
error of upto 7% in plasma and 6% for water. This error is
the same as the reproducibility of the assays and quite
acceptible; there is no obvious reason for the interaction
and it is likely that replicate matrices rather than just
one matrix would show no significant interaction.
2. Lactulose and mannitol.
Principle.
Lactulose and mannitol were assayed by the method of
Laker (Laker, 1979; and Laker & Mount 1980) with
modifications. This method used sulphosalicylic acid to
deproteinise the plasma, Zerolit DM-F to desalt the plasma
supernatant and urine, and air at 50°C to dry the resulting
samples. The last traces of water were removed by leaving
the samples in an evacuated dessicator containing
phosphorous pentoxide for atleast half an hour before
derivatisation with pyridine/bis(trimethylsilyl)-
acetamide/tri-methylchlorosilane 2/1/1 by volume, the
trimethylchlorosilane being necessary to act as catalyst for
the silylation. The derivatised samples were analysed by gas
liquid chromatography on a stationary phase of 3% OV-17. The
advantages of this method were that it was more robust than
the thin layer chromatography used in intestinal
permeability studies in adults (Wheeler et al, 1978), the
derivatives could be injected directly onto the
chromatographic column and be detected by flame-ionization,
and lactulose could be measured merely by adjusting the run
conditions.
As there was already much expertise and equipment in the
department for the measurement of organic acids using
capillary gas chromatography, it was decided to use these
facilities and modify Laker's method accordingly. The gas
chromatographs in the department were 588OA Hewlitt Packard
gas chromatographs with 10 x 0.001m CP-SIL-5CB fused silica
capillary columns.
Capillary GC method for mannitol estimation.
Adapting Laker's method to suit capillary gas
chromatography involved altering the run conditions and
extracting the neutral fraction rather than the acidic
fraction (Chalmers & Lawson, 1982).
Assay technique:
Urine samples (1 ml of the sample itself + 1 ml
internal standard, c£- methylglucose) were extracted
with miniature DEAE sephadex columns (2ml) poured into
pipettes and retained by glass wool. Plasma (0.5 ml
diluted with 2 ml distilled water) was rendered
slightly alkaline by the addition of sufficient 0.1 M
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sodium hydroxide to cause a change in litmus paper (to
minimise adherence to the cones) and ultrafiltered by
centrifugation through Amicon CF ultrafiltration
membrane cones before application to the DEAE sephadex
column. The neutral fraction was eluted with water (10
ml) , shell frozen over a mixture of solid carbon
dioxide and ethanol, and then freeze dried. Once this
was completed (usually overnight) tetracosane and
hexacosane (25 1) were added as GC standards and
derivitisation undertaken with trimethylsilylimidazole
(200 ^jl for plasma, 500 1 for urine). 1 Jul of the
resulting solution was injected onto the column. The
carrier gas was helium, flow rate approximately 1.4
ml.min"1, injector temperature 200°C, detector
temperature 300°C, and oven temperature programmed
from 150°C to 250°C at 8°C.min_1 and held constant for
the final 5 minutes. TMSI was chosen because it gave
better derivitisation than BSTFA
(bis (trimethylsilyl)trifluoroacetamide) which under
certain run conditions gave more than one peak for
mannitol and glucose, presumably due to variable
anomerisation.
The data analysis was controlled by a BASIC
programme 'AUTO CAP RI-X/2+PW'. This saved the raw
data and printed a report containing the retention
time, rentention index, peak height, peak area and the
relative peak area. Retention indices were calculated
with reference to the cosane standards injected before
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each run; the relative peak area was calculated with
reference to the tetracosane. The measured
concentration of mannitol in each sample was
calculated manually with reference to the internal
standard methylglucose by the equation,




In water, plasma, and urine the standard curve
for mannitol was linear over the range of mannitol
concentrations 0.01 - 2 mg.rnl"1. The response factor
as calculated from the slope of the standard curve was
not unity; each monosaccharide from a range of common
monosaccharides examined had a different GC response
factor. The reproducibility of the assay was
approximately 5%.
Combined gas chromatography-mass spectrometry (Mrs BM
Tracey) was used to confirm that the hexatrimethylsilyl
derivative of mannitol was being formed (Laker & Mount,
198 0) , that the same derivative was being formed when both
urine and plasma were derivatized, and that it was mannitol
that was being measured in these fluids.
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Gas chromatographic method for the measurement of mannitol
and lactulose.
As the study gained momentum, it became apparent that
there was not the time available on the capillary gas
chromatograph to analyse the samples for both mannitol and
lactulose. The assays were therefore transferred to a Pye
Series 2 04 gas chromatograph using a 3 x 0.005 m column of
3% 0V17 and were undertaken in conjunction with Miss D.
Copas and Dr MJ Landon.
Reagents:
The saccharides were obtained from the Sigma
Chemical Company, Poole, Dorset, the
tr imethy1silylimidazole from Pierce Chemicals,
Chester, Cheshire, DEAE Sephadex A-25 from Pharmacia
Ltd, Milton Keynes, Buckinghamshire, and
ultrafiltration cones from the Amicon Corporation, MA,
U.S.A.
Stock solutions of mannitol and lactulose 5 mg.
ml-1, and oCmethylglucose and D+ trehalose lOmg.ml"1
were prepared and used to make up the standards 0,
0.25, 0.5, 1, and 1.5 mg.ml-1. in either water if
urine was being assayed or pooled cord sera if serum
was being assayed.
Assay technique:
(1) Urine. To 0.5 ml of a 1:5 dilution of the
sample was added 0.1 ml of dCmethylglucose (5mg.ml-1)
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and 0.1 ml of D+ trehalose (5 mg.ml-1) and 0.3 ml of
distilled water. The ec methylglucose was the internal
standard for the mannitol assay and the D+ trehalose
the internal standard for the lactulose assay. Samples
were prepared in duplicate. The samples were extracted
by adding 2 ml of wet DEAE Sephadex, mixing, and
centrifuging for 5 minutes. The supernatant was
removed and 200 ^il blown down at 50°C under nitrogen
for atleast 30 minutes. Derivatisation was effected by
the addition of 50 ^1 of TMSI at 60°C for at least 30
minutes. 1 jul was injected on to the column. Mannnitol
estimations were run with temperatures of column
180°C, injector 250°C, and detector 300°C. Lactulose
estimations were run with a column temperature of
250°C, injector temperature of 300°C and detector
350°C.
(2) Serum and amniotic fluid. To 250 jil of
serum, 50 p.1 of oCmethylglucose (10 mg.ml"1), 50 ^il of
D+ trehalose and 150 jal of distilled water were added
and mixed. The samples were deproteinised by
ultracentrifugation using Amicon MP 51 ultrafiltration
cones, and then analysed in the same way as for urine.
The lower limits of the assays were 0.015 mg.ml"1




CrEDTA was assayed by electrothermal atomisation atomic
absorption spectrophotometry using totally pyrolytic
graphite cuvettes on a Pye Unicam SP9-800 atomic absorption
spectrometer with Pye Unicam video furnace and autosampler
by Dr A Taylor at the University of Guilford (Taylor &
Green, 1988). The urine was transferred immediately after
collection into chromium free tubes and stored frozen until
assayed. Serum was obtained by allowing the blood to clot
and then removing the serum to be stored frozen until
assayed; all the tubes and pipettes used were chromium free.
Estimation of molecular radius of CrEDTA.
The molecular radii of mannitol, lactulose and inulin are
well established in the literature (Normand, Olver,
Reynolds, et al, 1971) but this is not the case for CrEDTA.
CrEDTA has been used in intestinal permeability measurements
(Maxton et al, 1986), but in this and similar studies, the
molecular mass of CrEDTA (387) has been taken as a measure
of molecular size; any disparity between molecular weight
and molecular size for CrEDTA was unimportant as long as the
molecular radius was the same as, or greater than that of
lactulose, as both had similar permeability profiles.
The effective molecular radius of CrEDTA for diffusion
through an epithelial membrane will be influenced by the
hydration shell of the complex and whether there is
discrimination by the membrane on the basis of charge as
CrEDTA is a weakly charged anion. These considerations do
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not apply to the other three permeants used in the study.
Gel filtration chromatography is a well established
technique for determining molecular size using standards of
known molecular size to construct a calibration curve
against which the molecular size to be determined can be
calculated. Boyd et al, (1976) determined the Kav of
erythritol, mannitol, and sucrose, all of whose molecular
radii are well established, and that of CrEDTA on Sephadex
G-15 chromatography (30 x 1 cm column) . The Kav for CrEDTA
was smaller than that for sucrose indicating a larger
molecule size than the largest saccharide, sucrose. Linear
extrapolation from the three saccharides was therefore
required to estimate an effective molecular size for CrEDTA.
To properly measure the molecular size of CrEDTA requires
that it be within the range of the molecular size range of
the markers being used. The chromatography was therefore
repeated but with a larger molecular size marker at the
upper limit. Stachyose, mol. wt. 666, a tetrasaccharide (<*.-
D-Gal-oc-D-Gal-oc-D-Glu-S-D-Fru) , was chosen as the upper
molecular sized marker because of its larger size and its
terminal fructose residue allowing detection by the
Heyrovsky reaction.
Sephadex was prepared in a column 15 x 1 cm. De-gassed
phosphate buffeed saline, pH 7 (NaCl 9.3mM, KC1 0.2 mM,
Na2HPC>4 0.05mM, and KH2PO4) was used to both equilibrate and
elute the column. A solution containing 3[H] inulin 2.2
^Ci.ml"1, 51[Cr] EDTA 1.6 pCi.ml"1, 14[C] mannitol 21
^Ci.rnl"1, and 3[H] water 1.7 jJCi.ml-1 (all Amersham
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International PLC, Amersham, England), stachyose 4.2mg.ml_1
(Aldrich Chemical Company, Dorset, England) and lactulose
4.2 mg.rnl"1 (Sigma Chemical Company, Dorset, England) was
prepared. 7 0 Jv> 1 of this solution was applied to the column
and eluted at a flow rate of 2 ml.min"^-. 50 x 600 fJ 1
fractions were collected. An aliquot of each fraction was
assayed by the method of Heyrovsky (1956) and a further
aliquot mixed with 4 ml of NE265 liquid scintillant and
counted sequentially on a LKB 1215 Rackbeta and LKB 1280.
Both lactulose and stachyose were identified by a
positive Heyrovsky reaction. The fractions with the highest
activity of 3[H] water and 3[H] inulin were taken as V^-, the
total liquid volume, and VQ, the void volume, respectively.
Ve, the elution volume, was taken as the fraction with the
highest activity of the respective solute.
Manufacturing protocols.
Inulin, lactulose, and CrEDTA were prepared for
parenteral use and tested accordingly by the Pharmacy
Department at Northwick Park Hospital, Harrow.
1. Inulin.
Inulin was obtained as the pure powder from Koch-Light
Ltd, (Haverhill, Suffolk). A sterile solution of 12g.dl_1 in
O.Sg.dl""1 sodium chloride solution was made according to the
British Pharmacopoeia (British Pharmacopoeia 1980). Using
aseptic techniques 540g of inulin powder and 36g of sodium
chloride was dissolved at 75°C in 4.5L of sterilised
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distilled water. This solution was sterilized by aseptic
filtration through 0.22 filters before being dispensed
into individual sealed bottles each containing 150ml.
Pyrogen testing was performed in rabbits before the
resulting inulin solution was passed fit for human
intravenous use. With storage the inulin precipitated into
large flakes that were re-dissolved by heating to 80°C for
half an hour until no particulate matter remained. The
solution was then allowed to cool to room temperature before
being used for a patient-study later that day.
2. Lactulose.
Lactulose was prepared from the pure crystalline powder
which was a gift from Duphar Laboratories Ltd, Southampton.
250 g was disssolved in 1667 ml of sterile water for
injection. The resulting solution was sterilised by
filtration through 0.22 y. filters and checked for sterility
and toxiciy. The final solution contained lactulose 15 g.
dl"1.
3. Mannitol
Mannitol was obtained as a 20 g.dl-1 solution ready for
parenteral use (Polyfusor, Boots Co PLC, Nottingham).
4. CrEDTA.
CrEDTA suitable for parenteral use was prepared by the
same method used by Amersham International PLC to prepare
51CrEDTA (manufacture sheet kindly supplied by Amersham
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International PLC) with the difference that the starting
taterial was chromium (III) and with the obvious omission of
•adiolabelled chromium. The chromium EDTA complex was formed
>y heating an excess of the disodium salt of
ithylenediaminetetraacetic acid (EDTA) with the chromium
ialt and the subsequent addition of base to ensure
:omplexation is complete.
50 mg chromium (III) in the form of chromium chloride
Lexahydrate was dissolved with disodium edetate in 350 ml of
:resh distilled, sterile water. The resulting solution was
teated for one hour in a steam bath and within 10 minutes
:he solution turned a pale deep purple colour. The solution
ras then cooled and the pH adjusted to 3.5 - 4.0 with 1M
.odium hydroxide and the final volume brought to 500 ml
>efore being dispensed into 5 ml ampoules. The ampoules were
:hen sterilised by autoclaving and tested for sterility.
'reparation of the final infusate.
For studies using just mannitol and inulin, 150 ml of
.lready prepared inulin (12g.dl_1) was dissolved by heating
.n a water bath at approximately 80°C until the inulin was
:ully dissolved and the solution crystal clear. To this was
.septically added 150 ml of mannitol (20 g.dl-1) to give the
.dministered infusate of inulin 6 g.dl"1 and mannitol 10
r.dl"1.
For the studies using the four permeants, mannitol,
actulose, CrEDTA, and inulin it was felt more appropriate
.hat the pharmacy department should prepare the final
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solution under proper sterile conditions as three additions
were required rather than one as with mannitol and inulin
alone. The infusate was prepared by the addition of 150 ml
of inulin, 12g.dl-1; 10 ml of CrEDTA, 400 umol.l-1; 200 ml
lactulose, 15 g.dl-1; and mannitol 150 ml, 20 g.dl-1. The
final infusate with the four permeants thus consisted of
mannitol 6 g.dl-1, lactulose 6 g.dl-1, CrEDTA 8 nmole.ml-1,
and inulin 3.6 g.dl-1. The different infusion regimes
detailed on p 45 were to allow similar amounts of inulin and
mannitol to be given to the two groups of patient-studies.
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Chapter 4
Mathematical theory and analysis.
Derivation of permeability constants.
Transfer across the placenta like all biological
membranes is a two way process with transfer or flux, J,
occuring in both directions across the placental membrane,
namely Jm->f an<1 Jf->m* Ne^ transfer to the foetus, which
underlies its ability to accumulate nutrients is an absolute
prerequisite for growth, requires that flux from mother to
foetus exceeds the back flux from foetus to mother, namely
Jnet = Jm>f ~ Jf-»m
In the case of a foetal excretory metabolite, for example
urea, the equation expressed in this way would result in a
negative value for Jnef
Transfer by free diffusion across the placental membrane
can be described by the Fick equation which relates
the uni-directional flux per unit area of membrane to the
concentration on the donor side and a constant, P, the





and Jnet = (Cm - Cf) . P
where Cm : maternal concentration
Cf : foetal concentration
In whole organ studies the area of transfer cannot easily be
measured and the equation can be multiplied on both sides by
a surface area per unit weight term to produce a more
physiologically useful equation,
Jnet • s = (cm ~ cf) • p • s
Jnet : net flux per cm2 membrane
Cm : maternal concentration, mol.ml""1
Cf : foetal concentration, mol.ml-!
P : permeability cm.sec-!
S : surface area per gram cm2.g-l
The above equation can be rewritten in either of two forms
which relate net transfer to the whole placenta or per gram
placenta by a constant, the placental clearance K or KWf
respectively,




p . s = Jnet • s = Kwt (ml.min-1.g-1)
Cm " Cf
The measured placental clearance, K, is influenced not only
by the placental permeability, but also by the placental
blood flow. The importance of studying permeants which have
low placental clearances in relation to placental blood flow
(i.e. transfer is membrane limited) is thus clear if the
data is to be analysed in terms of membrane structure (see
section on pore theory).
To measure placental clearance or permeability, net
transfer and the concentration gradient down which this
transfer occurred must be measured. Fick's law applied to
transfer across the placenta requires the concentration
gradient to be measured to be that across the placental
membrane. Because the transfer of the four permeants being
studied is so low in comparison with the blood flows on
either side of the placenta, the maternal and foetal
concentrations on either side of the placental membrane will
approximate to the mixed venous concentrations that can be
measured peripherally. The mean transplacental concentration
gradient will thus equal the difference betweeen the
maternal and foetal blood profiles (fig 16) determined from
maternal venous blood, and cord blood taken at the time of
delivery. The foetal profile is constructed by joining the
level in cord blood which is at the end of the infusion with




















Fig 16. Maternal and cord serum profiles from a group 1 and
group 2 patient-study
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zero for the exogenous permeants.
For substances that are inert, non-metabolisable, and
wholly and solely cleared by renal excretion (the four
permeants in the study) , net flux to the foetus during
maternal infusion will equal their subsequent neonatal
urinary excretion.
The equation used to calculate placental clearance is
therefore,
Clearance, K, ml.min"1 = Net flux, mq
Mean cone diffce. x Duration
mg.ml"1 infusion
min
Passive permeability and the pore theory.
The Fick equation gives the rate of diffusion down a
concentration gradient,
dv Js -Do. A. dC (1)
dt dx
where dv/dt is the rate of diffusion in mol.sec"1, Js, dC/dx
the concentration gradient down which diffusion is occurring
in mol.ml-1.cm"1 (the negative sign indicates that diffusion
is taking place in the direction of the decreasing
concentration) , and A the area of the plane of solution at
right angles to the movement. The constant, Ds, is the
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diffusion coefficient which in the case of a solute free in
solution is the coefficient of free diffusion in water with
units of cm2.sec"1 or cm.sec"1.
The Fick equation can equally be applied to the passage
of substances across membranes by passive diffusion. The
constant, Dm, is however the diffusion coefficient in that
membrane, dCm/dx the gradient just within the membrane at
its outer and inner borders, and there is an additional term
PT, the partition coefficient, the ratio of the
concentration of the solute in the membrane to that in
aqueous solution when these are at equilibrium,
Jm ~ 2m—-—^m—i—£2m— • PT
dxm
(2)
where Jm: rate of diffusion
For any given cell membrane, thickness will be the same
for all solutes so that permeability will be determined by
the two constants for that membrane, the partition
coefficient and diffusion coefficient. For lipid soluble
substances, the direct proportionality between permeability
and the partition coefficient suggests that such substances
cross the membrane by dissolving in the lipid component of
the membrane (Fig 3). For small water soluble molecules this
relationship does not hold, and infact diffusion is related
primarily to molecular size, the permeability coefficient
being inversely proportional to the cube root of the
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molecular volume. Thus there arises the supposition that
hydrophilic molecules cross cell membranes largely or solely
by passive diffusion through water-filled pores or channels,
the so-called pore theory.
The thermodynamic analysis of diffusion through pores in
membranes, both biological and synthetic was unified by
Solomon in his now classic paper (Solomon, 1968) in which
Fick's original equation for diffusion was modified to
describe diffusion across membranes that still took place in
solution but limited to aqueous pores. The concentration
difference was measured in the opposite direction to produce
a change in sign, and a term As was introduced to describe
the additional restriction to free diffusion in solution
introduced by the pores,
Js = ^s • dC (3)
dx
The term As contained two components. The first, Ap/A the
ratio of total pore area to the total membrane area, and a
second term Ascj/Ap, which takes account of the frictional
resistance between the solute and the walls of the pore (the
Faxen term) and the steric hindrance at the pore entrance
(the Ferry term). Solomon (1968) agreed with previous
authors that the equation derived by Faxen is to be
preferred to that used by Pappenheimer in describing the
friction between solute molecules and the walls of the pore
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to give,
Ascj = (1 -oC)2. (1 - 2.104oC+ 2.09*3 - 0.95<*5)
AP
(4)
where cC = a/r the ratio of the radius of the solute molecule
a, to the pore radius, r. Applying the correction factor,
As, to the relationship between the permeability coefficient
and the diffusion coefficient (equation 3) allows
calculation of the pore radius from the permeability of the
membrane,
Ke - Ds . Am—.—Ap—!_Asd (5)
dx hn
- Ds . Ap—.—Ascj
dx Ap
= Ds . Ap . (1 - oC) 2. (1 - 2.104oC+ 2.09OC3 -0.95oC,5)
dx
(6)
Pore theory descibes the behaviour of small hydrophilic
molecules in terms of 'notional 1 pores without implying any
anatomical or structural characteristics.
Estimation of molecular size.
This was performed on Sephadex gel filtration
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chromatography. Separation by gel filtration chromatography,
of which Sephadex is one type, depends on the ability of the
sample molecule to enter pores contained within the gel.
These entrap some of the eluent, the stationary phase, and
access to this phase is governed by molecular size. The
smaller the molecule the more readily it enters the gel
pores, and thus the slower it moves through the column as it
spends longer in the pores. As Sephadex is a bead-formed gel
prepared by cross-linking dextran, the differing degree of
cross-linking allows beads with different pore sizes and
thus different fractionation ranges to be constructed
(Pharmacia, 1985).
Kav is one of the measures of the volume of the
stationary phase available for a given solute. It is
calculated from the relationship,
Kav = Ve - Vq
Vt " v0
where VQ is the void volume, the volume of the mobile phase
determined by the elution volume of a substance that is
excluded by the gel, Ve the elution volume, the volume at
which the sample elutes, and V-^ the total liquid volume or
volume of the packed bed, determined by the elution volume
of a substance that freely enters the gel. Because access to
the stationary phase is governed by molecular size Kav is
also a measure of the molecular size of the given solute
species.
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In attempting to derive a mathematical relationship
between Kav and molecular radius (R) various models for the
gel have been tried. Laurent and Killander (1964) assumed
the gel network to be composed of rigid rods randomly
arranged with the pores formed by this meshwork. A good
correlation was found between Kav and molecular radius with
this model but the relationship was sigmoidal. Siegel and
Monty took the same random meshwork model but linearized the
equations by logarithmic transformation to derive the
relationship (Rodbard, 1976),
y-log(Kav) = a + b.r
where a & b are constants
and r = molecular radius
Comoartmental analysis.
Compartmental analysis was used to quantify the error
introduced into the calculation of clearance by the
assumption of a linear rise in foetal permeant
concentrations whereas the rise would be more properly
described by an exponential function.
For this analysis the extracellular fluid space of mother
and foetus are considered as two compartments separated by a
permeable membrane. If a constant concentration of solute is
maintained in one compartment, the maternal compartment Cm,
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transfer to the other compartment, the foetal compartment
Cf, will be given by the exponential function (Moll,1981),
cf = CmC1 " e"kt) (7)
where t is time
The maternal-foetal profile can be expressed in one of
two ways: in units of absolute concentration against time,
or as the ratio of foetal:maternal concentration plotted
against time. In the former case the maternal:foetal
concentration gradient is the area between the two curves,
while in the latter case the maternal-foetal gradient is the
area between the curve of the ratio of foetal:maternal
concentration and unity. Expressing the foetal concentration
as a ratio of the maternal concentration allows the
application of compartmental analysis to express the
difference between an exponential and a linear rise in
foetal permeant concentrations as a function of
foetal:maternal permeant concentration at the time of
delivery.
The maximum ratio of Cf:Cm found experimentally at the
time of delivery was 0.7 for mannitol (the smallest permeant
studied and the most permeable). Applying equation (7) to
this ratio gives a corresponding value of kt equals 1.2. The
difference between a linear rise in the ratio of CfiC^ and
an exponential rise described by the above exponential is
equal to the area between the respective curves. This can be
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measured by integration of these curves between the limits
for kt of 0 and 1.2,
1.2 r
Cf. dt = (1 - e""^t) ...for exponential curve
-m 0 J
= 0.5
Cf.dt = 0.5 x 1.2 x 0.7 ...for linear curve
= 0.42
The error caused by assuming a linear as opposed to an
exponential increase is then given by comparison of the
areas beween the above curves and the boundaries of unity
equilibrium on the Cfi cm axis and 1.2 on the kt axis. This
is found by subtracting the area below the respective curves
(0.5 for the exponential curve, 0.42 for the linear curve as
determined above) from 1 x 1.2, which gives an area of 0.7
for the exponential increase and 0.78 for the linear
increase. The error is thus,
0.78 - 0.7 = 11%
0.7
A linear rise therefore underestimates the ratio Cf:Cm
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for the duration of the maternal infusion and this
corresponds to an overestimate of 11% in the mean maternal-
foetal concentration gradient for a ratio of 0.7 at
delivery.
Statistical analyses.
Statistical evaluation of the results was carried out by
means of a statistical package on an Apple II Europlus
computer or a Zenith personal computor. These allowed the
mean, standard deviation, and standard error, to be
determined for a set of results, a Student's t test to be
performed on two sets of data, and a paired t test or
Wilcoxon paired rank sum test to be performed on paired
data. The programmes also allowed the calculation of a
correlation coefficient between two sets of data using the
method of least squares analysis. The correlation
coefficient was converted into a two-tailed level of





Thirteen patient-studies were completed, 6 with infusions
of mannitol and inulin (group 1) and 7 with mannitol,
lactulose, CrEDTA, and inulin (group 2) . The reasons for
delivery by elective caesarean section are given in Table 4.
Table 4. Reasons for delivery by elective caesarean section.
Patient Reason for caesarean section
W Unstable lie at term with maternal age 39 years
McG Breech presentation with borderline pelvimetry in
primigravida
Fitz Breech presentation in primigravida with 3 years
of primary infertility
L Breech presentation in primigravida aged 39 years
1 Oblique lie, large baby, and failure of the foetus
to descend
K Two previous LSCS
BJ Three previous LSCS
Nas Two previous LSCS
Flet Two previous LSCS
0' R Two previous LSCS
Sha Two previous LSCS for cephalopelvic disproportion
Oreg Two previous LSCS, the first an emergency for
foetal distress
Mag Breech presentation with borderline pelvimetry in
a primigravida
Maternal clinical details are listed in Table 5. Maternal
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carried out under general anaesthetic and 3 under epidural.
One delivery (K) was at 37 completed weeks of gestation, the
rest were between 38 and 40 weeks.
All infants were delivered in good condition with APGAR
scores of 9 or 10 at both 1 and 5 minutes. None required any
resuscitation. No problems were detected at the first day
and discharge post-natal checks and mothers and babies were
discharged at the scheduled time. Neonatal clinical data are
contained in Tables 7 and 9. Five of the study infants were
exclusively breast fed, 5 exclusively bottle, and three
received a mixture of breast and bottle feeds. Six of the
infants were male and 7 female.
2. Blank values.
(i) Inulin. Blank values for inulin in cord blood ranged
from 20-30 jug.ml-1, mean 25 (n=6) and in amniotic fluid from
10-20 jug.ml"1, mean 15 (n=3). The pre-infusion maternal
blood sample was used to provide the maternal serum blank
value which was subtracted from the subsequent maternal
serum values; mean value of the maternal serum blank was 35
jag.ml~l (range 0 - 60) .
The cross-reacting substance(s) in neonatal urine were
separated from the true inulin by column chromatography. The
neonatal excretion rate of inulin fell to a 'baseline'
towards the end of the urine collection suggesting residual
interfering material (Fig 7) . This was confirmed by column
chromatography on the terminal neonatal urine specimens from






















































Neonatal urine at 54.5 hrs of age
25 50
Fraction Number
Fig 17. Chromatography of the terminal urine sample of the
neonatal urine collection in 3 patient-studies
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minimal inulin activity present. No inulin was identified in
neonatal urine samples collected at six days of age,
approximately 3 days after the period of urine collection
was finished, though the interfering substance appeared to
be less than in the terminal urine sample from the period of
urine collection. Column chromatography also allowed the
amount of interfering substance in the neonatal urinary
excretion to be quantified; it comprised from 25 to 45% of
the total urinary excretion corresponding to between 15-34
mg of inulin activity (see page 71).
(ii) CrEDTA. The chromium concentration was measured in
16 control patients and their babies at birth to detect any
maternal-foetal difference in chromium concentration. The
mean cord chromium concentration was 4.96 ± 0.73 nmol.l"1 (±
S.E. of mean) and mean maternal chromium concentration 7.42
± 1.23. The paired t test showed no significant difference
between the maternal and cord serum concentrations (p =
0.092) and neither did the Wilcoxon paired rank sum test (p
= 0.081).
From the control series amniotic fluid specimens were
obtained for chromium analysis and all contained <2 nmol.l"1
which is the lower limit of the assay. No correction was
therefore made for the endogenous chromium content of
amniotic fluid.
Blank values for neonatal urinary chromium excretion for
the period of urine collection were taken as the chromium
content of four of the six urine collections from the group
1 patient-studies. This gave a mean neonatal chromium
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excretion of 3.3 nmol over the 48 - 60 hours of urine
collection (range 2.1 - 4.2, n = 4).
(iii) Lactulose. There was no lactulose detectable in
samples of maternal sera taken before the infusion was begun
or in the series of uninfused cord sera.
Blank values for neonatal urinary lactulose excretion
over the period of urine collection were estimated from the
total lactulose content of five out of the six neonatal
urine collections in the first group of patient-studies.
This gave a mean value of 19 mg (mean, range 4.2 - 36, n =
5) ; two of these babies were entirely bottle fed, two fed
with a mixture of breast and bottle, and one entirely breast
fed. The lowest value of 4.2 was found in the breast fed
neonate, and the highest two values in the neonates who were
bottle fed, with intermediate values in the neonates fed a
combination of breast and bottle milk.
(iv) Mannitol. No mannitol was detected in the pre-
infusion samples of maternal sera or cord sera from the
series of uninfused pregnancies.
Mannitol was measured by the capillary GC method in pre-
infusion maternal urine samples of patient-studies in Group
1, and in samples of neonatal urine of uninfused
pregnancies. Three maternal urine samples contained mannitol
at concentrations of 0.01, 0.01, and 0.06 mg.ml-1, and three
neonatal urine samples all contained <0.005 mg.ml-1 of
mannitol.
3. Molecular size of CrEDTA.
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Four elutions were made on Sephadex G-15 to determine the
molecular size of the CrEDTA complex and one of these is
illustrated in Fig 18. The resultant Kav values for CrEDTA
and the molecular size standards, mannitol, lactulose, and
stachyose, together with other relevant data for the latter
are presented in Table 6. Plotting the negative logarithm of
the value of Kav for stachyose, lactulose, and mannitol
against molecular radius gave a straight line that allowed
interpolation of the molecular radius for CrEDTA giving a
value of 0.64 nm (fig 19).
Table 6. Some properties of the test molecules.






0.72 0.261 ± 0. 011
CrEDTA 387 0.64 0.323 ± 0. 001
Lactulose 342 0.51 0.446 ± 0.008
Mannitol 182 0.42 0.569 ± 0. 006
(1) As disodium EDTA complexed 1:1 with chromium.
(2) Molecular radius (as) in nm. from sources quoted in
Normand, Olver, Reynolds, & Strang (1971) (inulin,
lactulose, & mannitol) and Laurent & Killander (1964)
(stachyose), and as derived in the text (CrEDTA).
(3) Kav as measured in the text.
4. Serum profiles.
The profiles of maternal serum values and cord values for
patient-studies in group 1 and group 2 are shown in figures
20 - 26.
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mannitol were 66 ± 5% (mean ± S.E. of mean) of the
corresponding maternal values (at delivery) and 21 ± 3% for
inulin. The corresponding figures for the patient-studies in
group 2 were 37 ± 8 for inulin, 41 ± 3 for CrEDTA, 62 ± 5
for for lactulose, and 70 ± 3 for mannitol. Compartmental
analysis (see p 97) indicates that even when the ratio of
cord to maternal blood concentration at delivery reaches 0.7
as is the case for mannitol, assuming a linear rise in
foetal blood levels will overestimate the maternal-foetal
concentration gradient during the infusion by only 11%.
In the group one studies, mean cord levels (for duration
of infusion) were 10 ± 2% of mean maternal levels (± S.E. of
mean) for inulin and 34 ± 3% for mannitol. Similarily in the
patient-studies in group 2, mean cord levels as a percentage
of mean maternal levels were 17 ± 3% for inulin, 24 ± 3% for
CrEDTA, 32 ± 3% for lactulose and 39 ± 2% for mannitol.
The mean transplacental concentration gradients are
listed in Tables 8 and 10.
i
5. Determined values for placental clearance.
The variables required for the calculation of placental
clearance for each of the permeants in both groups of study-
patients are listed in Tables 8 and 10: the net flux to the
foetus, the transplacental concentration gradient, and the
infusion time.
In the group 1 patient-studies the mean mannitol
clearance was 7.3 ± 0.8 ml.min-1 (± S.E. of mean) and for
inulin 0.86 ± 0.1 and in the patient-studies of group 2, 8.7
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Table 7. Neonatal details for group 1 patient-studies.
Patient W MoG Fitz L 11 K
Birth weight 4.4 3.5 3.0 3.5 3.6 2.
of infant (kg)
Placental 890 590 490 690 560 560
weight (g)
Sex of infant M M F F M M
Length of 120 80 103 122 116 152
infusion (min)
Feeding Br+Bt Bt BrfBt BrfBt Br Bt
Br., breast, Bt., bottle
Table 8. Permeability data in group 1 patient-studies.
Patient W MoG Fitz L 11 K
Mannitol
Mean conc. gradient 285 410 392 458 369 438
(pg.ml-1)
Net foetal flux 286 340 265 339 334 315
(nig)
Clearance (ml.min-1) 8.4 10.4 6.6 6.1 7.8 4.7
Conc. in amniotic NA 175 125 NA 0 280
fluid (pg.ml-1)
Inulin
Mean conc. gradient 213 589 453 384 412 433
(pg.ml-1 )
Net foetal flux 32.3 31.8 31.4 40.9 44.8 47.3
(mg)
Clearance (ml.min-1) 1.26 0.67 0.67 0.87 0.94 0.72
Conc in amniotic NA 65 45 NA 15 45
fluid (pg.ml-1)
NA., no fluid available
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Table 9. Neonatal details for group 2 patient-studies.
Patient BJ Nas Flet O'R Sha Oreg Mag
Birth weght 2.94 3.12 3.0 2.94 3.36 3.22! 3.34
of infant (kg)
Placental 630 520 570 600 590 610 540
weight (g)
Sex of infant F F F F M F M
Length of 152 100 99 129 94 90 169
infusion (min)
Feeding Bt Bt Bt Br Br Br Br
Bt., bottle, Br., breast
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Table 10. Permeability data in group 2 patient-studies.
Patient BT Nash Flet O'R Shah Oreg Mag
Mannitol
306 363 350 381 281 301 345
393 451 236 215 267 307 423
8.5 12.4 6.8 4.4 10.1 11.3 7.3
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± 1.1 for mannitol, 6.3 ± 0.8 for lactulose, 3.7 ± 0.5
for CrEDTA, and 0.98 ± 0.1 for inulin. There was no
significant difference between the determined
clearances for mannitol (p>0.1) and inulin (p>0.1)
between patient-study groups 1 and 2. The mean
mannitol clearance for all 13 patient-studies was 8.1
± 0.7 ml.min-1 and for inulin 0.92 ± 0.07, (mean ±
5.E. of mean).
Expressing the clearance values per unit weight
placenta (g) , i.e. a permeability surface area
product, did not alter the range of values for each
permeant, there still remaining an approximately 2
fold difference between the highest and lowest value
for inulin and a 3 fold difference for mannitol
6. Correlates of the determined values for placental
clearance.
The determined values for placental clearance were
tested for correlation against :-
type of infant feeding, breast or bottle. There was
no significant difference between the clearances of
either breast or bottle fed infants, for mannitol
(p>0.5) and inulin (p>0.05) n = 10, for lactulose
(p>0.1) n=7, and CrEDTA (p>0.5) n = 6.
sex of the infant. There was no consistent
significant difference between the clearances of
study- patients with male or female infants, mannitol
(p>0.5) n = 13, lactulose (p>0.05) n = 7, inulin
(p>0.5) n = 13, and CrEDTA (p=0.02) n = 6 (2 male and -
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4 female infants).
anaesthetic, general or epidural. The type of
anaesthetic did not affect the determined placental
clearance, mannitol (p>0.5) n = 13, lactulose (p>0.5)
n = 7, and inulin (p>0.5) n = 13. Statistics could not
be used for the clearance of CrEDTA as 5 of these
patient- studies had general anaesthetics (range 2.4-
5.1 ml.min-1) and only 1 an epidural (5.3 ml.min-1).
maternal age. The maternal age showed no
significant correlation with the determined values for
clearance, mannitol r = 0.225 and n = 13 (p>0.1),
lactulose r = 0.347 and n = 7 (p>0.1), CrEDTA r =
-0.510 and n = 6 (p>0.1), and inulin r = 0.146 and n =
13 (p>0.1).
placental weight, foetal weight (i.e. birth
weight) and combined foetal-placental weight. There
was no correlation between placental weight and the
determined values for clearance, mannitol r = -0.012
and n = 13 (p>0.1), lactulose r = -0.20 and n = 7
(p>0.1), CrEDTA r = 0.08 and n = 6 (p>0.1), and inulin
r = 0.37 and n = 13 (p>0.1). There was a similar lack
of correlation (p>0.1 in all cases) when foetal and
foetal-placental weight were considered.
infusion time. Overall there was no consistent
correlation between the determined values for
clearance and length of infusion, mannitol r = -0.56
and n = 13 (p = 0.05), lactulose r = -0.55 and n = 7
(p>0.1) , CrEDTA r = - 0.59 and n = 6 (p>0.1), and
inulin r = 0.496 and n = 13 (p>0.1). The correlation
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just achieved significance at the 5% level for
mannitol, but not with any of the other three
permeants.
When the ratio of the clearances of mannitol to
inulin are correlated with time a correlation does
appear: slope - 0.098, r = -0.674, n = 13 and
0.02>p>0.01 for the clearance per whole placenta and
slope -0.098, r = -0.669, n = 13 and 0.02>p>0.01 for
the clearance expressed per unit weight (g) placenta.
Smoking. Six of the mothers were smokers and of
these 2 stopped smoking during pregnancy leaving 4 who
smoked throughout pregnancy. Seven of the mothers were
non-smokers. Even by counting those mothers who
stopped smoking during pregnancy with those who
continued to smoke, the numbers are still too small to
be certain of any discernable effect of smoking (Fig
26) .
Molecular size. The reduction in placental
permeability (clearance per gram placenta) with
increasing molecular size of each permeant is
illustrated in Fig 27 for each of the patient-studies.
7. Amniotic fluid.
The concentration of each of the permeants in the
amniotic fluid is listed in tables 8 and 10. The effect of
including the amniotic content as part of the flux to the






















Fig 26. Relationship between placental permeability and
smoking habits
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8. 'in-vivo' versus 1in-vitro'.
Subsequent 'in-vitro' perfusion of the placenta was
possible in a total of 9 of the patient-studies; 3 with
mannitol alone, 2 with inulin alone, 3 with mannitol and
inulin simultaneously, and 1 with mannitol and CrEDTA
simultaneously (Landon, Bain, Copas, & Stacey, 1991). The
results of the consecutive 'in-vivo' and 1 in-vitro1
perfusions are compared with the results for all 13 ' in-
vivo' studies and those from a set of 'in-vitro1 perfusions
derived by pooling the 1in-vitro1 results from the current
study with those of a larger, separate, and single permeant
per placenta study (Landon, et al, 1991) Fig 28.
The inulin clearances for the consecutive 'in-vivo1 and
'in-vitro' studies were 0.0083 ± 0.0017 •in-vitro' (mean ±
S.E. of mean) ml.min.g~1 and 0.0015 ± 0.0002 1in-vivo', both
n = 5; for mannitol 'in-vitro' the clearance was 0.031 ±
0.0042 and 0.011 ± 0.0013 'in-vivo1, n = 7. The ratio of the
clearances 1in-vivo• to ' in-vitro' for mannitol and inulin
are included in fig 28 and show a much wider spread for
inulin than mannitol, inulin range 2.5 to 11.5, mean 6.0;
mannitol range 1.4 to 5.2, mean 2.9. Thus 1in-vitro'
perfusion increases the measured placental clearances found
'in-vivo' and this increase is greater for the larger
molecule inulin. The 3 cases perfused simultaneously both
'in-vivo' and ' in-vitro' with inulin and mannitol and the 1
case similarily perfused with mannitol and CrEDTA (Fig 29),
confirmed this effect of 'in-vitro1 perfusion of the
placental lobule.
The ratios of the clearances 1 in-vitro' closely
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approximates to that of the ratios of their coefficients of
free diffusion which is not the case for the ratios of the
clearances 'in-vivo' (Fig 29). This loss of size selectivity
on 'in-vitro' perfusion is demonstrated in Table 11 which
uses the three possible ratios and the mean placental
clearances from the 13 1in-vivo1 patient-studies and the
pooled 'in-vitro1 data.
9. Volume of distribution.
A volume of distribution in the foetus at birth for each
permeant can be calculated from the equation,
volume of distribution = net foetal flux fmg) x 1
(ml.kg"1 body weight) cord conc. ( g.ml"1) birth weight (kg)
Using the data given in Tables 8 & 10, a volume of
distribution of 240 ± 20 ml.kg"1 body weight (mean ± S.E. of
mean) was obtained for mannitol, 240 ± 20 for lactulose, 240
± 50 for CrEDTA,and 120 ± 20 for inulin. There was no signif¬
icant correlation between the volume of distribution of each
permeant and the infusion time: inulin, slope = 0.12, r =
0.417, n = 13, p>0.1,; lactulose, slope = -0.06, r = -0.35, n
= 7, p>0.1; CrEDTA, slope = 0.3, r = 0.72, n = 6, p>0.1,; and
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■Fig 29. Placental permeabilities and ratio of these permeabilities
for the^ 4 patient-studies where 2 permeants were studied
sequentially 'in-vivo' & 'in-vitro' in the same placenta.
Ma., mannitol; In., inulin. Mean & SE for all 1in-vivo' &
'in-vitro' studies is given where applicable.































In measuring placental clearance by the above technique
several potential sources of error have to be considered.
(1) The solutes have to be inert, non-metabolizable, to
cross epithelia only by passive diffusion, and be excreted
wholly and solely by the kidneys. It is generally accepted
that all the four permeants used in this study meet these
criteria.
(2) The measurement of foetal flux is totally dependant on
adequate urine collection. The babies were nursed with their
mothers on busy postnatal wards where they received no
additional attention because of the study. The urine
collection system was therefore devised to require as little
attention as possible. The adhesive was effective at keeping
the plastic urine bag adherant to the perineum, but immersion
in meconium and stool caused it to fail after some time.
Breast fed babies with their more frequent bowel actions and
more watery stool were worse than bottle fed babies in this
regard. During the period of urine collection the babies were
visited every 3-4 hours during the day to collect the urine
passed and to check that the urine bag was still adequately
stuck on the perineum. Sometimes the urine bag had to be
changed at intervals as short as every 12 hours, and at other
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times it would function perfectly well for periods of up to
30 hours. The adequacy of the urine collection could be
fairly well assesed by the number of wet nappies. A number of
urine collections were obviously lost due to failure of the
adhesive, but these were fortunately all after the first 24
hours. As can be seen from fig 12, most of the permeant had
been excreted by this time and this source of error should
therefore be minimal.
(3) The maternal concentration profile was derived by
joining the data points with straight lines. This will tend
to under estimate the mean concentration before the first
sampling point as the concentration of permeant rises from
zero to its peak. This error for the rest of the maternal
profile should be much less as the concentration fluctuates
much less and the fluctuation is in both directions. The
foetal profile was derived by joining the single data point
obtained from cord blood at delivery to the origin by a
straight line. The actual rise of the foetal serum
concentration will however be exponential and compartmental
analysis allows measurement of this introduced error which is
variable and dependent on the final ratio between foetal and
maternal concentrations. Mannitol has the highest ratio of
0.7, as would be expected being the smallest and most
permeable molecule, and assuming a linear rise in foetal
serum concentrations as opposed to an exponential rise
overestimates the mean maternal-foetal concentration gradient
by 11%. Assuming a steady-state, this corresponds to an
underestimate of 16% in mean foetal concentrations. The
corresponding error for a linear rise in foetal
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concentrations of the other permeants would be less. These
errors in calculating mean maternal and foetal
concentrations, both underestimates will tend to be self-
cancelling as they are subtracted from each other in the
calculation of the clearance.
As the errors introduced by the above simplifications will
increase with time causing a progressive overestimate of
clearance with time, the lack of any significant correlation
between the clearance values for each permeant and the length
of infusion supports the contention that the errors
introduced by these mathematical assumptions is insignificant
compared to the individual variation in placental clearance
and the errors inherent in all the measurements. The
correlation between the ratio of the clearances of mannitol
to inulin and the length of the infusion could be due to many
factors singly, or in combination. The correlation may be due
to chance as it only achieved significance at the 2% level.
The error in the assumptions obviously increases with time
and this will be most marked with the most permeable
permeant, namely mannitol. It is interesting therefore that
mannitol does show a correlation with the length of infusion
that only just reaches the 5% level of significance.
(4) The significance of the amount of permeant in the
amniotic fluid and whether it should be included as part of
the net foetal flux is contentious. If the permeant in the
amniotic fluid arises solely from the placenta and foetal
urinary excretion, then it should properly be included in the
calculation of placental clearance. If, on the other hand, it
arises from direct transfer across the foetal membranes
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independent of the foetal-placental unit, then it should not
be included in the calculations. There is unfortunately no
precedent in the literature to clarify which approach is
correct. Willis et al (1986) from Oregon University measured
the permeability of the placenta to cyanocobalamin and
excluded the amniotic fluid content in the measurement of
flux to the foetus on the grounds that its content was
negligible, 320 ng assuming an amniotic fluid volume of 1
litre compared with a foetal content of 4.5 ^ig. In a
subsequent publication from the same group however, Thornburg
et al (1989) included the amniotic fluid content of inulin as
part of the measured flux to the foetus and therefore
included it in the calculation of the placental clearance of
inulin. Indeed, the mean inulin content of the amniotic fluid
was twice that of the foetus while in one case it was nine
times the foetal content. Unfortunately inulin cannot be
directly compared with cyanocobalamin as the latter is
protein bound in the plasma and in tissues and only when this
capacity is exceeded is there significant renal clearance.
There is already evidence from the literature that direct
transfer occurs across the extra-placental foetal membranes
from maternal blood directly into the amniotic fluid
bypassing the foetus. In the original report by Basso et al
(1977) demonstrating that mannitol was mostly entering the
amniotic fluid through foetal micturition, one pregnancy with
a dead foetus was described. In that pregnency the levels of
mannitol in amniotic fluid rose only slowly and did not
exceed those in maternal blood, indicating that some mannitol
was being transferred directly from the maternal vascular
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space to the amniotic fluid bypassing the placenta. Super,
Fennell, Schwartz & Boyd (1986) have recently reported that
the usual form of non-specific cholinesterase in amniotic
fluid is of maternal not foetal origin. This contrasts with
the specific acetylcholinesterase which is of foetal origin
and used in the diagnosis of neural tube defects (Seller &
Cole, 1980). Johnson, Umansky, Alper, et al (1974) analysed
the correlation between the ratio of the concentration of
several proteins in amniotic fluid and maternal blood with
their molecular weight and compared this with the correlation
of the ratio between the concentrations in amniotic fluid and
cord blood with molecular weight. The correlation was
significantly closer (r=-0.925, p<0.0005) and there was much
less scatter about the least-squares regression line with the
amniotic fluid : maternal blood ratio, than amniotic fluid :
cord blood ratio (r=-0.6767, p=0.02) over a molecular weight
range 40,000 to 800,000. This indicates that amniotic fluid
proteins in general are primarily a simple filtrate of
maternal plasma. The concordance with maternal genotype for
the two proteins examined (MW 44,000 and 51,000) rather than
foetal genotype provides confirmation of the maternal origin
of these proteins and indicates that the foetal contribution
to the amniotic fluid is less than between 2-10 percent,
the lower limit of sensitivity of the technique, certainly
for these two proteins and most probably for proteins of
higher molecular weight. The passive transfer of plasma
proteins indicates a route that would be available for the
passive transfer of the much smaller inulin molecule.
The amniotic fluid content of the permeants depends not
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only on their measured concentration, but on the measured
amniotic fluid volume as well. Measurements of amniotic fluid
volume are notoriously difficult to make in routine clinical
practice.
In the current study the origin of the permeant in the
amniotic fluid might be checked in two ways. Firstly, it is
possible to determine whether the amniotic fluid content
could be accounted for by the estimated foetal urine
production rate. Such a back calculation was possible only
for study K, however, because the individual urines were only
assayed in the patient-studies in Group 1, amniotic fluid was
not obtained from every patient, and a urine sample at birth
was available from only a few patient-studies (Table 11). In
patient-study K the first urine at birth contained inulin at
0.375 mg.ml"1 and mannitol at 1.8 mg.ml"1. Assuming an
amniotic volume of 1 litre (Lind 1981), this corresponds to a
minimum foetal urine production of 47 ml.hr"1 for inulin and
61 ml.hr"1 for mannitol. The data of Thornberg et al, (1988)
allows a similar analysis in their patient number 3 with a
quoted neonatal urinary inulin concentration of 147 jig.ml"1
in the presumed first urine specimen passed, giving a foetal
urine production rate of 600 ml over a mean infusion period
of 3 hours (± 1.75, the SD) . These figures compare with the
published fetal urine production rate of 23 - 28 ml.hr"1 for
term infants (Campbell, Wladimiroff, & Dewhurst, 1973) found
by serial measurements of bladder volume by ultrasound. This
is strong evidence that fetal urine is unlikely to be the
sole source of the permeant in amniotic fluid.
A second possible indication of the origin of the
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permeants in amniotic fluid would be their ratios (cf Johnson
et al, 1974) . If foetal in origin, the ratio of mannitol to
inulin concentration in amniotic fluid should resemble the
ratio in either cord blood or the neonatal urine at birth. If
maternal in origin, the ratio should resemble that found in
maternal blood as certainly the extra-placental membranes
permit the passsage of large protein molecules. Unfortunately
the data (Table 12) are insufficient to allow a definitive
conclusion.
It is impossible to distinguish between, and measure
separately, that proportion of permeant derived from foetal
micturition and that derived from other sources. If the
amniotic fluid content is included as part of the foetal flux
then the clearances will increase as illustrated in Table 13
which assumes an amniotic fluid volume of 1 litre. This
increase shows marked variability between patient-studies and
between the different permeants used. In the group 2 patient-
studies, including the amniotic fluid content of permeant in
the net flux to the foetus increases the clearance for inulin
by 150%, that for CrEDTA by 60%, and that for lactulose and
mannitol by 25%. The relatively greater amniotic fluid
content relative to foetal content for inulin and to a much
lesser extent for CrEDTA compared wth mannitol and lactulose,
does not fit with either a foetal or extra-placental origin.
It is more likely due to the insensitivity of the inulin
assay at the low concentrations found in amniotic fluid (at
the limit of sensitivity of the assay a small change in
optical density can double the inulin content which is
magnified by the correction for the 1:10 dilution) and the
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presence of a variable but more equal background level. Both
these factors would apply to a much lesser extent to the
assay for chromium.
With all the above uncertainties over the amniotic fluid
content of permeant, it is probably more realistic at the
present time to express the results excluding it.
(5) Validity of the assumed model. The calculation of
placental clearance assumes a two compartment model, namely
maternal and foetal, with equilibration across the placental
membrane with no additional compartments. The maternal
infusion achieves near steady-state levels in the maternal
compartment, but there remains the possibility of a slowly
equilibrating compartment in the foetus. The lack of any
significant correlation of clearance with time indicates the
absence of a significant additional compartment in the
foetus, as this would lead to a progressive underestimate of
the net foetal flux and therefore a fall in clearance with
time. A two compartment model therefore appears to apply for
the length of infusion period used.
The significance of the errors inherent in the method has
to be seen in the context of a 2 - 3 fold variation in
placental clearance between individuals, that is likely to
dwarf any experimental error.
Comparison with other available data.
Molecular size of CrEDTA. The data of Boyd et al (1976)
can be used to derive a molecular radius for CrEDTA when the
negative logarithms of the Kav values are plotted against
the molecular radius. This gives a straight line and a
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molecular radius for CrEDTA of 0.65 nm (Fig 19), almost
identical to the value found in the present study of 0.64 nm
for the molecular radius of CrEDTA.
Both the human placenta 'in-vivo' and Sephadex gel handle
CrEDTA as if it were a larger molecule than suggested by the
molecular weight. It is well recognised that filtration
through Sephadex can be affected by the charge carried on a
small molecule, and as CrEDTA is a weakly charged anion, it
is possibile that the placenta, like Sephadex gel, is
discriminating against the charge on the CrEDTA molecule. An
alternative explanation for the discrepancy in apparent size
molecular may relate to a hydration shell around the CrEDTA
molecule, though it is interesting that Bradbury (Hedley &
Bradbury, 1980) suggested that the guinea pig placenta may
discriminate against molecular charge.
'In-vivo1 human studies. The only directly comparable
data on 1in-vivo' placental clearances in man are those of
Willis et al (1986) using cyanocobalamin and Thornburg et al
(1988) who used inulin. Both these studies originated from
the Department of Physiology in Oregon and used parenteral
administration of a single permeant to achieve adequate
maternal levels; in the case of cyanocobalamin a single
intramuscular injection was used, while inulin was
administered as a bolus followed by a continuous infusion.
The same mathematical principles as in the current study
were employed to calculate a maternal-foetal gradient.
Compared to the present study, the study period as quoted
was shorter for cyanocobalamin, average 42 min, range 27-
110 but longer for inulin, 176 ± 107 min (mean ± S.D.).
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These two studies differed in three important methodological
aspects from the current study.
Firstly, the maternal-foetal flux, equal to the
accumulation by the foetus, was calculated in both studies
not from the subsequent neonatal excretion but from a cord
blood value multiplied by a putative factor for the volume
of distribution derived from parallel studies on guinea
pigs. This effectively replaces errors in urine collection
which are quantifiable with the errors implicit in applying
a factor derived in another species without validation. The
guinea pig placenta differs from the human placenta in being
a much smaller proportion of the foetal weight than the
human, 7% in Willis et al's study (1986) as opposed to the
18% in the current study. Willis et al (1986) measured the
volume of distribution factor as 280 ml.kg-1 body weight
plus placental weight for cyanocobalamin corresponding to
300 ml.kg-1 body weight alone (mean placental weight 7% of
foetal weight) and Thornburg et al (1988) measured a
corresponding figure of 180 ml.kg"1 body weight for the
volume of distribution of inulin. These figures compare with
the volumes of distribution from the current study of 240
ml.kg-1 body weight for CrEDTA, the nearest permeant in size
to cyanocobalamin, and 120 ml. kg"1 for inulin. All these
figures compare with other estimates of extracellular fluid
space in healthy term neonates of approximately 380 ml.kg"1
(Cassady, 1970). This would suggest that none of the
permeants was evenly distributed throughout the
extracellular fluid space during the period of infusion.
Secondly, cobalamin is a normal tissue component that is
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vital for normal tissue metabolism and for which there are
specific carrier mediated transport mechanisms and metabolic
pathways. Although Willis et al (1986) attempted to saturate
the endogenous tissue mechanisms by using large doses of
cyanocobalamin such that diffusional transfer would
predominate, there remains doubt as to the contribution of
carrier mediated transfer and the extent to which metabolism
may occur. Cyanocobalamin transfer does not therefore solely
measure passive diffusion.
Thirdly, the amniotic fluid content was included as part
of the net foetal flux when the inulin clearance was
measured but excluded when the clearance of cyanocobalamin
was determined.
Considering the differences outlined above, the values
for the placental clearances of cyanocobalamin and inulin
measured in the studies by Willis et al (1986) and Thornburg
et al (1988) are of the same order of magnitude as those
found in this study. For cyanocobalamin, a value of 9.6
ml.min"1 was measured, just over twice the value of slightly
less than 4 ml.min"1 predicted by the current data, this
being the clearance value for CrEDTA, the nearest permeant
in the current series. For inulin, excluding the amniotic
fluid content, Thornburg et al (1988) found a mean inulin
clearance of 1.4 ml.min"1, guite close to the figure of 0.9
ml.min"1 for all 13 patient-studies in the present study;
the difference can be largely accounted for by the different
volumes of distribution between the two studies.
Faber and Thornburg (1983) have recalculated the data of
Flexner et al (1948) to give a permeability surface area
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product for sodium in the human of 3.4 x 10~2 ml.min^.g"1.
Sodium, however is not an inert permeant and the data is not r
directly comparable with that of the current study.
'In-vitro1 human studies. The current data for 1 in-
vivo1 placental clearances expressed per unit weight of
placenta, i.e. ml.min^.g-1, are compared with the results
of 'in-vitro' perfusion of the placental lobule from Landon
et al (1991) and Schneider, Sodha, Proegler, and Young
(1985) in Table 14.
Table 14 Comparison with 'in-vitro1 perfusion data.
Permeant (MW) Current data Proegler et al1 Landon et al2
(ml.min-1.g-1) (ml.min-1.g-1) (ml.min-1.g-1)
Mannitol (182) 13.5 x 10"3 25.6 x 10"3
L-Glucose (182) - 23 x 10"3 -
Lactulose (342) 10.8 X 10"3 - . -
Sucrose (342) - 19 x 10~3 -
CrEDIA (387) 6.33 X 10~3 - 21.0 x 10"3
Inulin (5200) 1.53 X 10~3 6 x 10"3 7.5 X 10~3
1 Data from Schneider et al (1985)
2 Data from Landon et al (1991)
The comparison in Table 14 indicates the close agreement
between the results of 1in-vitro• perfusion of the placental
lobule by Landon et al (1991) at the centre where the
current work was undertaken and Schneider et al (1985) but
with an obvious difference between both these 'in-vitro'
studies and the present 'in-vivo' studies. Not only does the
placental lobule perfused 'in-vitro1 have a greater
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clearance than that measured 'in-vivo', but the difference
between the 'in vitro' and • in-vivo' data is greater with
inulin (approximately 5 times) than with mannitol
(approximately 2 times). The ratio of the clearances in the
current study (Figs 28 & 29) clearly indicates that while
the 'in-vivo' data indicates molecular size restriction by
the placenta (clearance ratios greater than corresponding
ratios of coefficients of free diffusion), 'in-vitro'
perfusion reveals a placental membrane that shows no
molecular size discrimination between mannitol and inulin
(clearance ratios equal corresponding ratios of coefficients
of free diffusion).
The reason for the discrepancy between the clearances
measured 'in-vivo' and 'in-vitro' is not yet clear. 'In-
vitro' perfusion of the placental lobule does not duplicate
the blood flows found 'in-vivo', which in any case are not
yet defined, and this is evidenced by 2 observations.
Firstly, •in-vitro' perfusion attempted through the
umbilical artery is unsuccessful due to the inordinately
high pressures required to generate flow and is only
successful when a foetal artery and vein on the periphery of
a placental lobule are used. The foetal vasculature is not
therefore behaving as it does 'in-vivo'. Secondly, doubling
the number of cannulae perfusing the intervillous space
(i.e. the maternal side) but keeping the the overall
perfusion rate rate unchanged (i.e. flow per cannula
halved), causes a significant drop in measured placental
clearance (Landon MJ, personal communication).
While changes in flow rate 'in-vitro' could increase the
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measured clearances by increasing placental transfer in
poorly perfused areas of the placenta (increased efficiency
of placental transfer), there should not be any effect on
the molecular seiving properties of the placental membrane,
that is, there should be no effect on the mannitol to inulin
clearance ratio which there clearly is. This loss of size
restriction when the placenta is perfused 'in-vitro'
indicates that more than flow has been altered because size
discrimination is a fundamental characteristic of the
placental membrane itself. The technique of 'in-vitro1
perfusion of the placental lobule is rarely succesful with
blood as perfusate and physiological replacements for blood
are routinely used instead; if the perfusate contains
fibrinogen, fibrin is deposited in the placenta and if red
cells are used in the perfusate they must be washed. The
effect of 'in-vitro1 perfusion therefore very much
ressembles the 'protein effect' observed when albumin is
washed out of capillaries during physiological studies of
capillary permeability and which has been used as evidence
for the fibre matrix theory of capillary permeability
(Levick, 1991).
While attempts to assess the metabolic and structural
viability of the 'in-vitro' perfused placental lobule have
demonstrated the preparation to be intact within the limits
of the parameters assessed, no tests of any transfer
function were carried out (Illsley, Aarnoudse, Penfold et
al, 1984) . The four sequential studies (Fig 29) avoid the
difficulty of trying to distinguish any effect of 'in-vitro'
perfusion from a two to three fold variation in placental
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permeability between individuals. They confirm the effect of
'in-vitro' perfusion as increasing the measured values for
placental clearance and as eliminating size discrimination
by the placental membrane. Although one of the three
placentas that was perfused both •in-vivo• and 1in-vitro'
had a mannitol to inulin clearance ratio that equalled the
ratio of the coefficients of free diffusion (patient-study,
O'R), this was the only patient-study to demonstrate such a
low ratio (high inulin and low mannitol clearance) and was
not distinguishable from the other patient-studies in any
methodological or clinical characteristic.
Hedley & Bradbury (1980) have already demonstrated that
'in-situ• perfusion of the guinea pig placenta using a
physiological perfusate increases the measured placental
permeability, by 84% for erythritol (MW 122) , 234% for
CrEDTA, and 263% for FITC dextran (MW 3000) . This is very
similar to the situation found in the human placenta by the
current study and provides a precedent for significant
distortion of placental transfer by the technique of ' in-
vitro • perfusion. Robinson et al (1988) however, compared
'in-vivo• and 'in-situ' perfusion of the rat placenta and
were unable to show any significant difference in placental
permeability between these two situations; interestingly,
the standard error of the mean measured 1in-situ1 was
greater that measured •in-vivo1 and this was quite marked
for the permeants mannitol and inulin. The reason for the
resistence of the rat placenta to perfusional change in
permeability is unclear at present.
Animal studies. The comparable animal data tabulated in
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Table 1 is presented graphically with the current placental
permeability data again expressed per unit weight of
placenta (Fig 30) . This shows that the current data most
closely resemble those of the guinea pig, rat, and rabbit.
These animals have placental permeabilities all within an
order of magnitude of the human, with a similar overall
decrease in permeability with increasing molecular size. The
different profile of the rabbit and one set of data for the
guinea pig is due entirely due to one datum point in each
study. The contrast of the profiles of these animals and
that found in the present study for the human with that of
the sheep is striking.
Figure 30 also emphasises two other features of
placental permeability in man and the rabbit, guinea pig,
and rat. Firstly, there is an approximately fifteen fold
variation between these species in the permeability to any
given permeant in the molecular weight range studied and
secondly, this compares with a 10 fold variation in
permeability with molecular size. The human placenta is
haemomonochorial in structure like the guinea pig, while the
rabbit is haemodichorial, the rat haemotrichorial, and the
sheep epitheliochorial.
None of the animal placentas studied so far has been shown
to have exactly the same permeability characteristics as the
human placenta over a wide range of substances. The passive
permeabilities of haemochorial placentas as a group are
quite similar over the molecular size range of 180 to 5000
and this contrasts quite sharply with the corresponding
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Fig 30. Comparison of the 1in-vivo' human placental
permeability data with equivalent data for other
animal species. Ma., mannitol; Su., sucrose; Lact.,
lactulose; Raff., raffinose; B]_2 • / cobalamin;
FITC., fluorescein-labelled dextran, molecular
weight 3000; & In., inulin
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sheep. A similar variation with placental structure is also
found for the placental permeability for sodium (Moll,
1985) , but a totally different relationship between
placental structure and permeability is revealed by gas
transfer across the placenta. Placental diffusing capacity
(a measure of permeability to gases) to carbon monoxide is
very similar in the rhesus monkey (haemochorial) and sheep
(epitheliochorial) but 20 times less than that of the guinea
pig (haemochorial) when expressed per unit placental weight
(Faber & Thornburg, 1983).
While the differences in passive permeabilities between
species are quite obvious, the biological meaning of these
differences remains obscure (Moll, 1985). The sheep placenta
has a preplacental arterial blood pressure of 80% of central
arterial while in the haemochorial placentas examined (Moll,
1985) the preplacental blood pressure varied between 8 to
18%. The tightness of the sheep placenta may reflect this
high pressure.
Physiological implications of the permeability data.
The 'in-vivo' permeability data for the human placenta
derived above allow further understanding of both the nature
of the placental barrier and the functional consequences of
the barrier as they affect the ability of the placenta to
meet the nutritional and excretory requirements of the
developing foetus.
1. The nature of the placental barrier.
The placenta is an anatomical barrier that separates the
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maternal and foetal vascular compartments, yet has to allow
sufficient exchange between these compartments to meet the
foetal nutritional and excretory requirements. It is already
recognised that this anatomical barrier also provides a
barrier to free exchange between mother and foetus (Stacey
1985) . Although IgG can cross the placenta, mainly in the
third trimester and probably by receptor mediated
endocytosis, the much larger immunoglobulin IgM cannot and
its presence in the foetus is indicative of foetal
production. The early studies by Gitlin and colleagues
(Gitlin et al, 1964, and Gitlin & Gitlin, 1975) demonstrated
the impermeability of the placenta to quite small proteins
by measuring the appearance of radioiodinated proteins in
the foetus after injection into the maternal circulation.
The transfer rate was found to be very low indeed. Transfer
studies with iodinated compounds have had their
difficulties, but these results accord with other evidence.
Thus neonates born with the rare genetic variant of
analbuminaemia would not be born with almost undetectable
plasma albumin concentrations were it not for the
impermeability of the placenta to albumin. Likewise,
congenital nephrotic syndrome would be corrected in utero if
the placenta were permeable to albumin.
Johnson et al (1974) examined the discordance between the
haplotypes of various plasma proteins in the maternal and
foetal circulations. Out of 10 cases examined, there was
discordance in four between the maternal and foetal (as
determined from cord blood) haplotypes for orosomucoid, a
protein with molecular weight 44,000, indicating the
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placenta to be impermeable to this protein and by inference,
molecules of similar size. In their study with 125[I]
insulin, molecular weight 5733, Kalhan et al, (1975) found
that after 1 hour of a constant rate maternal infusion the
umbilical venous count was only 1% of maternal venous blood
and concluded that at term there was no significant
maternal-foetal transfer in man. Insulin can however cross
the placenta to the foetus. A recent study on the placental
transfer of insulin in man (Menon, Cohen, Sperling, et al,
1990) for example, demonstrated a relation between the
placental transfer of porcine, bovine, or synthetic human
insulin and the level of maternal antibody to these
insulins, indicative of antibody-mediated transfer. This is
analogous to the situation found in the guinea pig placenta
where Thorell (Thorell, 1966) demonstrated that insulin
crosses the guinea pig placenta bound to maternal antibodies
but with no transfer of insulin to the foetus in the absence
of maternal antibodies.
The molecular weight of insulin is 5733, only slightly
greater than that of the largest permeant, inulin, used in
current study and insulin might therefore be expected to
cross the placenta if the only criterion were molecular
weight. The reason for the measured impermeability of the
human placenta to insulin is not yet clear. The plasma half-
life of intravenously administered insulin is at most 30
minutes due to rapid clearance by many tissues including the
placenta, and a slow transfer, as might be expected from the
present data, may remain undetected by the sort of technique
used by Kalhan et al (1975). Alternatively, the placental
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transfer of insulin may indeed be insignificant and the
explanation for its this may lie in the size or shape of the
insulin molecule, discrimination by the placenta on the
basis of surface charge, the existence of insulin in
polymeric forms in solution, or simply very effective
placental uptake and metabolism.
The measured clearances for the four permeants indicate
that while the human placenta is permeable to molecules up
to the size of inulin, somewhere above this molecular size
and below that of orosomucoid, this permeability is
apparently lost. Further work is obviously required to
define the upper limit of placental passive permeability.
A clearance value for inulin of 0.9 ml.min"1 and 8
ml.min"1 for mannitol compares with estimates of placental
blood flow of 500 ml.min"1 in the uterine artery and 300
ml.min"1 in the umbilical artery at term (Faber & Thornburg,
1983) . The figures for blood flow correspond to plasma flows
of approximately 300 amd 160 ml.min"1 respectively and these
are the more relevant flows when considering the passive
permeability measured in the current study as the permeants
do not enter red cells. The determined clearance values are
low when compared to both the maternal and foetal flows,
blood or plasma, on either side of the placenta. The
clearance values are measures of the permeability of the
placenta and cannot be directly compared with the maternal
and foetal blood flows; carbon monoxide a small molecule
with a high lipid solubility for example, has a clearance in
man of 294.6 x 103 ml.min"1. The exact relation between the
placental clearance and placental blood flows depends on the
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precise anatomical relations of the the maternal and foetal
blood flows, concurrent, countercurrent, or some other type.
Faber and Thornburg (1983) in a mathematical analysis of a
variety of placental blood flow models, found that the
transfer of substances with placental clearances less than
66 ml.min-1 was always limited by the permeability of the
placenta while for substances with clearances greater than
4400 ml.min"1 the transfer was not limited by the
permeability, that is, was governed by the blood flows on
either side of the placenta. Though in the human the
relations of the flows is unproven, these calculations by
Faber and Thornburg agree with the general belief that the
clearances of small hydrophilic molecules will be
descriptive of the membrane characteristics compared with
the permeability to respiratory gases.
While anatomical shunting (blood not reaching the exchange
area) and mismatch (blood flows not matched on either side
of the exchange area) of the two circulations occurs in
animal placentas it is unlikely to be of the magnitude
required to be the sole explanation for the low clearances
observed in the human placenta 'in-vivo'. Measurements of
shunting have varied from 19% of umbilical flow in the
sheep, 23% of umbilical and 36% of uterine flow in the goat,
and 2% of umbilical flow in the guinea pig (Faber &
Thornburg, 1983) . Shunting of these orders of magnitude is
insufficient to render the placental transfer of the
permeants studied flow limited and the low measured
clearances found in the human placenta 'in-vivo' are likely
therefore to be a reflection of a significant barrier to
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passive diffusion.
Nature of the placental membrane hvdroohilic pathways.
The permeability profile of the four permeants allows the
placental barrier to hydrophilic substances to be analysed
in terms of the pore theory. Boyd et al (1976) performed
such an analysis on the 1in-vivo1 permeability of the sheep
placenta to radiolabelled urea, erythritol, and mannitol,
and showed that the data was consistent with diffusion via
cylindrical, water-filled pores of a uniform diameter of
0.43 to 0.45 nm. Stulc et al, (1969), had previously
analysed similar permeability data (water, urea, erythritol,
mannitol, sucrose, inulin and albulmin) in the rabbit and
found that the data from the rabbit were incompatible with
an isoporous model and required atleast two distinct
populations of different sized pores, a large population of
small pores of radius 0.3 nm and a small population of large
pores of radius 10 nm. Hedley and Bradbury (1980) reported a
similar finding in the guinea pig. Analysing the
permeability data for radiolabelled Na, K, erythritol and
CrEDTA and native FITC Dextran 3000 and 20000, these authors
found the data again required two different populations of
pores, one with a radius of 10 nm allowing the passage of
CrEDTA and the two Dextrans and another with a radius of 0.3
nm allowing the transfer of erythritol, Na, and K. Robinson
et al (1988) have recently reported permeability studies in
the rat placenta using the same sized permeants
(radiolabelled) as the current study, mannitol, sucrose,
CrEDTA, and inulin, but with the addition of radiolabelled
Na and albumin. These data indicated a single population of
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pores allowing the passage of the four intermediate sized
permeants mannitol, sucrose, CrEDTA, and inulin, but the
transfer of Na required a different route that could
represent a second population of smaller sized pores. The
similarity between the computed figures for equivalent pore
radii in the guinea pig and rabbit is striking.
The current 'in-vivo• permeability data for the human
placenta can also be analysed by pore theory to determine
whether the • in-vivo' placental permeability data is
compatible with a uniporous model as is the case for the
sheep (Boyd et al, 197 6) or a non-uniporous or multiporous
model as suggested for the rabbit (Stulc et al, 1969),
guinea pig (Hedly & Bradbury, 1980), and rat (Stulc, 1989).
Back-calculating using the Faxen-Ferry term, the
permeability for mannitol is converted into the notional
permeability corresponding to unrestricted diffusion through
a given pore size. This notional permeability can be used to
construct a permeability profile on the basis of
unrestricted diffusion, as on a log-log plot of permeability
versus molecular radius the slope of this line will be -1.
Applying the Faxen-Ferry term to the line so constructed for
each pore size, the degree of restricted diffusion to the
molecular size of each permeant allows the profile of
placental permeability to be determined for different pore
radii (Levick, 1991) Fig 31. This analysis was done
graphically demonstrating that a single pore radius cannot
accomodate all the data? the best fit is with a pore radius
of 5 - 6 nm which poorly accomodates the data for CrEDTA.
When the data from individual patient-studies are considered
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Placental permeability profiles for a single pore
radius (r) of either 5 or 6 nm calculated with
reference to mannitol. The measured 'in-vivo'
permeant permeabilities are mean ± S.E. of mean
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separately they deviate even further from a uniporous model.
The permeability data therefore better fit a multiporous
model when analyzed terms of pore theory.
Distribution of permeability within the placental barrier.
The site or sites of the barrier to passive diffusion
within the placental membrane in the human is as yet
unclear. The placental membrane is composed of several
different layers that will differ in their permeability
properties, and the overall permeability of the membrane
will represent the summation of its component layers. It is
most unlikely that these characteristics will be vested in
one layer alone: classically, epithelia such as the
trophoblast are 'tight', restricting transfer by passive
diffusion whereas capillary endothelia (with the exception
of the brain) are much more permeable allowing the transfer
of large molecules such as plasma proteins.
The relative contributions of the individual tissue
layers to the overall permeability of the placental membrane
to hydrophilic molecules of different size has been studied
in the rabbit placenta by Thornburg & Faber (1976). These
authors found that more than 90% of the diffusion resistence
(diffusion resistence is the inverse of permeability, PS) to
small hydrophilic molecules was 'provided by the inner layer
of the trophoblast, while the foetal capillary wall
contributed only some 5 - 10 %. The foetal capillary wall
did, however, significantly restrict the transplacental
diffusion of the large molecule, transferrin (MW 1 x 106
daltons), 55% of the resistence residing in the capillary
endothelium and 41% in the cytotrophoblast and 4% in the
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syncitiotrophoblast. Stulc (1989) has recently analysed the
permeability data for the rabbit and rat placenta obtained
in his laboratory in terms of two porous membranes in
series, a low permeability, large pore membrane representing
placental trophoblast, and a high permebility small pore
membrane, representing the foetal capillary wall. The fit
with this model was very good. In the sheep both the
trophoblast and capillary endothelium are tight preventing
the transfer of molecules larger than disaccharides (Boyd et
al, 1983).
Studies with membrane vesicles demonstrate that the
trophoblastic cell membrane of the human placenta is tight
and relatively impermeable even to the passive diffusion of
small molecules, for example mannitol and sucrose are used
as buffers to prevent osmotic changes in placental membrane
vesicle preparations (Bissonnette, 1982). The outer layer of
the trophoblast is a syncytium, the syncytiotrophoblast,
with therefore few if any paracellular channels. All aqueous
pores in this layer must therefore be transcellular and
large enough to allow the passage of molecules up to the
size of inulin. This is in contrast to the the absorptive
epithelium, the intestinal mucosa (Menzies, 1984), where
there is strong evidence of atleast 2 populations of
different sized pores, the small pores being transcellular
and permitting diffusion of molecules up to the size of
monosaccharides, and the larger pores paracellular for the
transfer of larger molecules.
There are no lymphatics on the foetal side of the
placenta and no lymphatic connection between the umbilical
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cord and the foetal body (Boyd & Hamilton, 19 67) . The
absence of any lymphatic drainage would imply little lymph
production which inturn would require a tight capillary
endothelium relatively impermeable to albumin as albumin is
the major osmotically active protein in lymph (conc. 15-20
g.l-1 depending on the organ in question, and a slightly
higher percentage of the total protein content than in
plasma) . The lack of a lymphatic drainage system in other
animals studied has been associated with a high diffusion
resistance to large molecules in the foetal capillary
endothelium in the sheep (Boyd et al, 1983) and the guinea
pig (Thornburg & Faber, 1976). There is other indirect
evidence for a significant contribution to diffusion
resistence from the foetal capillary in the human. Proteins
produced by the trophoblast itself, such as placental
lactogen and placental alkaline phosphatase appear in the
maternal circulation in considerable quantities, but do not
accumulate in the foetus. On the other hand, proteins
produced within the foetus itself such as oc-fetoprotein and
growth hormone remain at high concentrations in foetal
plasma, but are found at very much lower concentrations in
maternal plasma (by four orders of magnitude in the case of
a-fetoprotein) (Stacey, 1990).
2. Functional consequences of the placental barrier.
The placental barrier is obviously necessary to maintain
the separate integrity of the maternal and foetal
circulations and separate the immunologically different
mother from her foetus. All exchange between the maternal
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and foetal vascular compartments in the human occurs across
the placenta. Owens and Robinson (1988) listed the placental
characteristics determining foetal-maternal exchange for
various substrates, Table 14.
Table 14. Placental characteristics determining
foetal-maternal exchange of various substrates.
Rates of maternal and foetal placental blood flow
Vascular arrangements of maternal and foetal blood vessels
Permeability of the placental membrane: surface area and
physical properties
Mechanisms for carrier-borne transport
Placental utilization
The importance of placental permeability to normal foetal
growth and development is demonstrated by the way in which
all the pertinent properties of the placental membrane that
determine its permeablity increase with foetal growth. In
the sheep, placental clearance of urea increases with
gestational age and is proportional to foetal rather that
placental weight. A logarithmic increase also occurs in the
last third of gestation when placental weight and DNA
content are constant but foetal weight is increasing (Moll,
1985). Flexner and Pohl (1941) measured the permeability for
sodium in the guinea pig and here too, in spite of a large
scatter of the data, there was a proportional relationship
between permeability and foetal weight.
160.
There is much experimental evidence, stronger in animals,
linking reduced placental transfer with foetal growth,
summarized by Owens and Robinson (1988). In the human,
chronic maternal undernutrition is associated with reduced
placental and foetal weight, and any reduced uterine blood
flow is associated with an increased risk of intra-uterine
growth retardation. In women living at high altitude there
is a decrease in average birth weight that has been
interpreted as a response to restricted availability to the
foetus of oxygen, a major foetal substrate. The positive
association between placental and foetal weight is, however,
not strong evidence for substrate limitation of foetal
growth as the placenta is a foetal organ and might therefore
be expected to parallel any change in the foetus.
In animals, attempts to limit placental function either
by reducing placental size or embolization of part of the
vascular bed, result in reduced uterine blood flow. In most
of these studies, reduced blood flow was correlated with
reduced foetal weight and this has been interpreted as the
restriction of foetal growth by flow limited transfer rather
than membrane limited transfer though other effects were not
excluded. Few measurements of passive permeability following
manipulation of placental growth have been undertaken.
Spontaneously occurring small placentas in sheep have been
reported as having normal permeability to urea when
expressed as a measure of placental weight, and surgical
reduction in placental size in the sheep produced a similar
result. Both these observations indicate that placental
permeability will decrease with placental size leading to
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the possibility that under the right circumstances,
placental permeability may become growth limiting.
The lack of correlation in the present study between
placental growth and placental clearance indicates that
while passive permeability appears to be important for
foetal growth (Moll, 1985), at term and in normal
pregnancies with birth weights ranging from 2.9 to 4.4 kg,
placental permeability does not appear to be limiting foetal
growth.
Substrate transfer across the placenta.
The determined values for placental clearance are
measures of the amount of placental transfer available to
the foetus by passive diffusion across the placental
barrier. They therefore allow an assessment of whether any
special transfer mechanisms are required to meet the foetal
requirement or whether passive diffusion alone is
sufficient.
Glucose has the same molecular size and lipid solubility
as mannitol and will have an identical placental clearance
by passive diffusion. The foetal glucose requirements at
term have been estimated by several different authors using
several different approaches and they all give figures in
the range of 4 - 8 mg glucose.kg"1.min"1 (Battaglia &
Sparks, 1983). The maternal-foetal concentration gradient
has been measured and found to be approximately 0.07 mg.ml"1
(Oakley, Beard, & Turner, 1972). Using turnover techniques
with isotopically labelled 1-13[C] glucose, Kalhan and
colleages (1979) were able to demonstrate that, at term but
before the onset of labour, the foetus in utero produces no
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glucose and that the foetal glucose is entirely maternal in
origin. Taking 0.07 mg.ml""1 as the maternal concentration
gradient of glucose and the foetal glucose consumption and
applying the equation for the calculation of clearance
(p 90), a figure of 340 ml.min-1 is obtained. This is the
notional clearance of glucose that would be required if
passive diffusion were the only means of placental transfer
and this is 40 times greater than the 8 ml.min""1 measured
for mannitol. Clearly difffusional transfer alone is
insufficient to meet the estimated placental transfer rate
of glucose and it is necessary to postulate carrier-mediated
transfer of glucose. Widdas (1952) first suggested
facilitated carrier-mediated transfer for glucose transfer
from 'in-vivo• studies in the sheep, but definitive proof
was not obtained until 1977, when placental transfer in
the chronically catheterised sheep was studied using inert
analogues of glucose (Stacey et al, 1977). While L-glucose
had a placental clearance approximately similar to that of
mannitol, 3-methylglucose had a clearance two orders of
magnitude greater and this could only occur if there were
carrier-mediated transfer. The rate of transfer provided by
the carrier in the sheep is the same order of magnitude as
that which would be required in the human placenta.
Carrier-mediated transfer mechanisms have been
demonstrated in human • in-vitro' preparations of the
placenta and there is circumstantial evidence for them from
'in-vivo' studies. Thus Cordero et al (1970) studying short
glucose infusions in women, found a significant correlation
between maternal and foetal levels but with a ceiling or
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plateau (350 mg.dl"1) above which there was no further
increase in foetal levels. Oakley (1972) confirmed the above
concept of a ceiling for the placental transfer of glucose
but found the plateau to be lower at 2 00 mg.dl"1. The
existence of a plateau is evidence of saturation and this is
one of the hallmarks of carrier-mediated transfer. The
current study provides not only further direct evidence for
the existence •in-vivo' of carrier-mediated transfer for
glucose, but provides a reason for its necessity.
Data for other important metabolites can be similarly
analysed if a measure of foetal flux can be obtained. Urea,
molecular weight 60 daltons, has a transplacental fetal-
maternal concentration gradient of 25 jo g.ml"1 (Morriss &
Boyd, 1988) and a neonatal production rate estimated
at 200 mg.kg~1.day~1 for bottle fed infants (Ciba Geigy,
1981). Unfortunately the data available for production rate
calculated by Gresham, Simons & Battaglial (1971) assumed
for man the same placental clearance as the Rhesus monkey.
Taking the neonatal production rate as an estimate of intra¬
uterine production, this corresponds to a clearance for urea
of 15 ml.min"1 compared with 8 ml.min"1 for the measured
clearance of mannitol, a molecule twice its size. Assuming a
linear extrapolation of the current clearance data, passive
diffusion alone could provide for a clearance of 15
ml.min"1. Creatinine (MW 116) shows a neonatal production
rate of 1.7 mg.kg"1.day"1 (breast fed infants) (Ciba Geigy,
1981) and passive diffusion would only require a foetal-
maternal concentration gradient of 1 jL/g.ml"1 if placental
transfer were by passive diffusion alone. The absence of a
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readily identifiable transplacental concentration gradient
for creatinine (Morriss & Boyd, 1988) is most likely due to
the difficulty of detecting such a small gradient. The
ability of the placenta to meet the foetal excretory
requirement for creatinine and possibly urea by passive
diffusion alone would explain the absence to date of any
identifiable carrier-mediated transport mechanism for the
transfer of these substrates across the placenta.
In congenital hypothyroidism, the opposite situation
appears to pertain as passive diffusion cannot compensate
for foetal under-production of thyroid hormones. Infants
born at birth with this condition show evidence of intra¬
uterine thyroxine deficiency at birth, with abnormal
epiphyses and delayed ossification so that clearly the
placental clearance of thyroid hormones cannot compensate
for reduced foetal production. The neonatal replacement dose
of thyroxine of 25 yb'g.day"1 can be taken as an approximation
of foetal requirement. In the case of complete absence of
the thyroid where endogenous foetal production and levels
will be zero, the maternal levels of free plasma thyroxine
of 13 pg.ml"1 and free tri-iodothyronine of 5 pg.ml"1
(Kendall-Taylor, 1978) would require a passive clearance of
approximately 1000 ml.rnin"1. This is three orders of
magnitude greater than the combined clearance by passive
diffusion of both forms of the thyroxine based on molecular
size, which is intermediate between that of CrEDTA and
inulin, that is 1 - 4 ml.min-1. Without carrier-mediated
transport for thyroxine, for which there is no evidence,
placental transfer cannot ameliorate the consequences of
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congenital hypothyroidism by means of maternally derived
thyroid hormone.
Foetal Homeostasis.
The placenta does act as a significant barrier to the
free diffusion of substrates between mother and foetus. This
would have the advantage of allowing foetal homeostasis to a
greater or lesser extent to be independent of that of the
mother allowing the foetus for example, to accumulate and
retain iron even in the face of maternal deficiency with the
result that iron deficiency is virtually unknown in the
newborn. This would be of evolutionary advantage as although
maternal iron deficiency is rare in the developed world with
a good diet and small families, it is a common finding in
the developing world and is likely to have been a common
feature of evolutionary life. Moll (1985), also stresses the
evolutionary advantage of independent foetal homeostasis
protecting the foetus from transient harmful concentrations
of maternal metabolites that accumulate under stress, such
as during fight, flight, and fright. Thus transient maternal
lactic acidosis occurring in a cow has little impact on its
foetus because of the low placental permeability.
The degree of homeostatic independence of the mother thus
afforded by the placental barrier is however incomplete, and
not always beneficial. The placenta is unable to protect the
foetus from osmotic fluid shifts originating in the mother.
It is now well recognised that foetal hyponatraemia can
easily develop when the mother is given, not always large,
amounts of intravenous fluids of effectively low osmolality
(dextrose solutions) during the management of labour. The
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hyponatraemia can be quite severe indeed (Stacey, 1990).
Foetal independence due to low placental permeability may
thus be achieved at the cost of some restriction in the free





The technique of measuring the 'in-vivo1 permeability of
the human placenta described in this study provides direct
measurements of one of the most important functions of the
placenta, namely transfer between the maternal and foetal
compartments. Free diffusion is the simplest form of
transfer across biological membranes and is common to all
hydrophilic placental permeants. The only other direct
measure of placental transfer currently available is foetal
growth itself. All the other currently available measures of
so-called placental function concern other functions of the
placenta which are not directly related to nutrition of the
foetus, for example urinary oestriol excretion.
The measurements made in this study demonstrate that the
passive permeability of the human placental membrane is low
and that it presents a significant barrier to free
diffusion between maternal and foetal vascular compartments.
This means that for hydrophilic metabolites such as glucose
and amino acids, special transfer mechanisms are required to
meet foetal requirements as these latter exceed the rather
low limits of passive transfer imposed by the permeability
characteristics of the placenta. It would thus appear that
for glucose and probably amino acids, most of the placental
transfer occurs via carrier-mediated mechanisms and free
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diffusion makes little contribution to the net transfer; for
glucose some 3% of net foetal requirement appears to be met
by passive diffusion. Although not quantitatively important
for glucose and amino acid transfer, other experimental
evidence indicates that passive permeability is closely
correlated with foetal weight, and that this correlation is
not solely due to an increase in placental surface area as
it occurs despite a lag of chorionic surface area behind
foetal weight (Moll, 1985), implying a simultaneous increase
in membrane permeabilty. This precise adjustment of
placental permeabilty to foetal growth implies a functional
significance which may lie in foetal excretion rather than
foetal nutrition as free diffusion appears to be the only
mechanism for urea and creatinine excretion by the foetus.
Appreciation of placental permeability is important with
the increasing clinical intervention and use of
pharmaceuticals during pregnancy. A knowledge of the likely
transfer across the placenta of any agents so used will
allow prediction of their effect on the foetus. Thus
reference has already been made to the rapid fluid shifts
which can occur across the placenta and the caution which is
now used when fluids are administered during pregnancy. The
permeability of the placenta to molecules as large as inulin
indicates how easily hydrophilic agents can enter the foetal
compartment. Digoxin (MW 800) can cross the placenta and
must therefore be used with caution in pregnancy, but this
same transfer can be used therapeutically to control intra¬
uterine arrhythmias (Wladimiroff JW & Stewart PA, 1985).
The current research has highlighted the difficulties in
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choosing a suitable animal model for human placental
function as a similarity between the model and the human
placenta for one set of physiological characteristics does
not imply a corresponding similarity between any other sets.
•In-vitro' perfusion of the human placenta is also shown to
reproduce poorly, if at all, the passive permeability
characteristics found •in-vivo1. Attention had focused in
the past on these animal models and 'in-vitro1 studies as a
source of data relevant to the human because of the
difficulties in undertaking •in-vivo1 measurements in the
placenta of physiological and functional characteristics.
There is now developing the methodology for making other
measurements of physiological parameters of the placenta
'in-vivo' (Chien, Taylor, Scrimgeour et al, 1991). The
current study is in the vanguard of this developing field
which is all the more important given the limitations of
animal models and 1in-vitro1 perfusion.
The placental permeability data obtained in the current
study form the basis from which to proceed to study
placental transfer in pregnancies complicated by disordered
foetal growth, for example hypertensive disease of pregnancy
and idiopathic growth retardation, which is suspected in
part or in whole, to be due to reduced availability of
placental exchange to the foetus.
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